type sequence filename arwr description text doctype html public html transitional http html loose html head title arwr title head converter body style text align right margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal exhibit style text align right margin bottom margin text indent font weight bold font size nbsp style text align center margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal following notation this exhibit indicates that confidential portion been omitted pursuant request confidential treatment omitted material been filed separately with commission style margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal first collaboration license agreement style text align justify margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal name _dv_m name _dv_c name _dv_m name _dv_c this font style font weight bold font variant small first name _dv_m collaboration license agreement font font style font weight bold agreement font entered into september font style font weight bold effective date font between font style font weight bold font variant small amgen font font style font variant small font font style font weight bold font variant small font delaware corporation font style font weight bold amgen font font style font weight bold font font style font weight bold color font family time roman bold font variant small arrowhead pharmaceutical font font style color font family time roman bold font variant small font font style font weight bold color font family time roman bold font variant small font font style color delaware corporation font font style font weight bold arrowhead font nbsp nbsp arrowhead amgen sometimes referred herein individually font style font weight bold party font collectively font style font weight bold party font style text align center margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m recital style text align justify margin bottom margin text indent font weight bold font family time roman font variant small font size font style normal text transform none name _dv_m whereas font style font weight normal font variant normal arrowhead posse proprietary technology know related discovery identification synthesis development interference font font style font variant normal rnai font font style font weight normal font variant normal therapeutic using galnac liver targeting approach font style text align justify margin bottom margin text indent font weight bold font variant small font size font family time roman font style normal text transform none name _dv_m whereas font style font weight normal font variant normal amgen posse resource expertise development commercialization pharmaceutical product field medicine interested developing rnai therapeutic drug candidate such field font style text align justify margin bottom margin text indent font weight bold font family time roman font variant small font size font style normal text transform none name _dv_m whereas font style font weight normal font variant normal amgen arrowhead desire engage research collaboration pursuant which arrowhead will apply proprietary technology work development drug candidate specific target selected amgen pursuant which amgen will have option exercisable amgen sole discretion during specified period obtain exclusive license from arrowhead develop commercialize licensed product with respect such target following term condition font style text align justify margin bottom margin text indent font weight bold font family time roman font variant small font size font style normal text transform none whereas font style font weight normal font variant normal concurrently herewith party entering into common stock purchase agreement dated effective date font font style font variant normal stock purchase agreement font font style font weight normal font variant normal pursuant which amgen agrees purchase arrowhead agrees sell worth share common stock value share arrowhead font style text align justify margin bottom margin text indent font weight bold font variant small font size font family time roman font style normal text transform none name _dv_m therefore font style font weight normal font variant normal consideration foregoing premise mutual covenant condition contained this agreement party agree follows font style text align center margin bottom margin text indent font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal name _dv_m name _toc name _ref article font style font family time roman font weight normal text transform none name _ref font definition style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font font style font weight normal font acquiree font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font acquiror font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font acquisition font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _aeioulastrenderedpagebreakaeiou font style margin left font font style font weight normal font affiliate font style font weight normal mean with respect particular party person corporation partnership other entity that control controlled under common control with such font style margin line height margin bottom font size font family time roman font weight normal font style normal text transform none font variant normal text indent style line height margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal nbsp style line height margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal font style margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal party nbsp nbsp purpose this definition word control including with correlative meaning term controlled under common control with shall mean actual power either directly indirectly through more intermediary direct cause direction management policy such entity whether ownership fifty percent more voting stock such entity contract otherwise font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font agreement font style font weight normal meaning forth introductory paragraph font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _toc font style margin left font font style font weight normal font amgen font style font weight normal meaning forth introductory paragraph font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_c name _dv_m name _dv_m font style margin left font font style font weight normal font amgen collaboration result font style font weight normal name _dv_m mean collaboration result name _dv_c generated name _dv_m solely behalf amgen name _dv_m affiliate font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m name _dv_m font style margin left font font style font weight normal font amgen indemnitees font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font amgen withholding action font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font arrowhead font style font weight normal meaning forth introductory paragraph font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font font style font weight normal font arrowhead collaboration result font style font weight normal mean collaboration result generated solely behalf arrowhead affiliate font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font arrowhead indemnitees font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font font style font weight normal font arrowhead know font style font weight normal mean information controlled arrowhead affiliate effective date during term that used arrowhead affiliate research development rnai molecule prior effective date that used arrowhead affiliate course conducting activity under this agreement during term each case related development manufacturing commercialization licensed compound licensed product field that necessary reasonably useful development manufacturing commercialization sale offer sale importation other exploitation licensed compound licensed product field font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font arrowhead licensed technology font style font weight normal mean arrowhead know arrowhead patent arrowhead collaboration result nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font arrowhead patent font style font weight normal mean patent other than joint patent that controlled arrowhead affiliate effective date time during term absent license would infringed purpose pending patent application would infringed patent issued therefor with claim their then current form would reasonably necessary useful either case development manufacture commercialization sale offer sale importation other exploitation licensed compound licensed product field nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font arrowhead platform patent font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font arrowhead product patent font style font weight normal meaning forth section font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight bold font size font family time roman font style normal text transform none font variant normal arrowhead research deliverable font font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style font weight normal mean font font style font weight normal font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font arrowhead research font style font weight normal mean patent information controlled arrowhead affiliate during research term that necessary reasonably useful amgen conduct activity described under article solely connection with performance research program accordance with term this agreement nbsp nbsp clarity arrowhead research includes arrowhead collaboration result font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font background font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font bankruptcy code font style font weight normal mean title code section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font blocking patent font style font weight normal mean licensed compound licensed product patent right third party that claim particular country composition manufacture such licensed compound licensed product which such patent right would infringed manufacture offer sale sale import export such licensed compound licensed product such country font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font business font style font weight normal mean weekday that legal holiday york york which banking institution required closed font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font calendar quarter font style font weight normal mean respective period three consecutive calendar month ending march june september december provided however that first calendar quarter particular period shall extend from commencement such period first complete calendar quarter thereafter last calendar quarter shall upon expiration termination this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref font style margin left font font style font weight normal font calendar year font style font weight normal mean first calendar year term period beginning effective date ending december name _ref each calendar year term thereafter each successive period beginning january ending twelve consecutive calendar month later december last calendar year term period beginning january calendar year which agreement expires terminates ending effective date expiration termination this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m name _toc font style margin left font font style font weight normal font change control font style font weight normal mean occurrence following party enters into merger consolidation business combination recapitalization share exchange name _dv_m name _toc stock sale sale transfer substantially asset which this agreement relates other similar transaction series transaction with third party transaction series related transaction which third party group third party acquires beneficial ownership security party representing more than fifty percent combined voting power then outstanding security such party nbsp nbsp notwithstanding foregoing clause stock sale underwriter public offering party capital stock other third party solely purpose financing transaction solely change domicile party shall constitute change control font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font claim font style font weight normal meaning forth section font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight normal font font style font weight bold font size font family time roman font style normal text transform none font variant normal clinical trial font font style font weight normal mean human clinical trial licensed product font font style font weight normal fined font font style font weight normal font font style font weight normal equivalent font font style font weight normal human clinical trial prescribed regulatory authority foreign country font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font code font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font collaboration result font style font weight normal mean information generated under research program whether behalf arrowhead amgen their respective affiliate either name _dv_m solely jointly font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m font style margin left font font style font weight normal font collaboration target font style font weight normal mean target identified font font style text decoration underline font weight normal exhibit font font style font weight normal name _dv_m font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font combination product font style font weight normal mean licensed product sold combination with least additional pharmaceutical product other than licensed compound font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font commercialization font style font weight normal mean marketing promotion sale distribution other activity relating commercialization licensed product field territory font commercialize font style font weight normal font font style font weight normal correlative meaning font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc name _toc name _dv_c name _dv_m name _dv_m name _dv_c name _dv_m name _dv_c name _dv_c name _dv_c font style margin left font font style font weight normal font commercially reasonable effort font style font weight normal name _dv_c mean name _dv_m name _dv_m with respect party obligation under this agreement name _dv_c during research term level name _dv_m effort resource reasonably required carry such obligation hereunder consistent with effort resource such party normally relating discovery development name _dv_c biopharmaceutical product name _dv_c with respect party obligation under this agreement following amgen exercise option case amgen name _dv_c with respect licensed product effort consistent with effort resource normally used similarly situated pharmaceutical biotechnology company exercise reasonable business discretion relating development commercialization pharmaceutical product with similar product characteristic that similar market potential similar stage development commercialization case either party taking into account other relevant factor including technical legal intellectual property competition scientific medical factor font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font competing product font style font weight normal mean compound directed collaboration target font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font competing program font style font weight normal mean research development commercialization manufacture territory competing product font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc name _ref font style margin left font font style font weight normal font confidentiality agreement font style font weight normal mean collectively confidential disclosure agreement between arrowhead amgen effective april amended confidential disclosure agreement between arrowhead amgen effective august font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _dv_m name _aeioulastrenderedpagebreakaeiou font style margin left font font style font weight normal font confidential information font style font weight normal party mean information such party third party that disclosed party other party under this agreement except otherwise forth article otherwise expressly forth this agreement whether oral writt name _dv_m graphic electronic form nbsp nbsp information disclosed party pursuant font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal font font style font weight normal confidentiality font font style font weight normal agreement shall font font style font weight normal deemed such party confidential information disclosed hereunder with mutual understanding agreement that disclosure thereof that authorized under font font style font weight normal article font font style font weight normal shall restricted deemed violation confidentiality agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc name _dv_m font style margin left font font style font weight normal font control font style font weight normal mean with respect information intellectual property right that entity owns right grant access license sublicense applicable such information intellectual property right term condition forth this agreement without violating term then existing agreement with third party requiring payment whether then payable with respect grant exercise such access license sublicense under then existing agreement with third party unless other party agrees writing responsible such payment name _dv_m nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font font style font weight normal font cure period font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font development font style font weight normal mean activity that relate obtaining maintaining expanding regulatory approval licensed product including preclinical testing toxicology formulation clinical trial preparation submission review development data information purpose submission governmental authority obtain maintain expand regulatory approval licensed product nbsp nbsp font develop font style font weight normal font name _dv_m font style font weight normal font developing font style font weight normal font font style font weight normal have correlative meaning font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font font style font weight normal font dispute font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _toc font style margin left font font style font weight normal font dollar font style font weight normal mean dollar font font style font weight normal name _toc shall interpreted accordingly font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m font style margin left font font style font weight normal name _dv_m font effective date font style font weight normal meaning forth introductory paragraph font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font font style font weight normal mean european medicine agency successor entity font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m font style margin left font font style font weight normal font executive officer font style font weight normal mean with respect arrowhead chief executive officer with respect amgen designated official shall vice president higher with authority resolve such matter font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font font style font weight normal mean federal food drug cosmetic amended applicable regulation promulgated thereunder font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font font style font weight normal font font style font weight normal mean food drug administration successor entity font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m name _toc font style margin left font font style font weight normal font first commercial sale font style font weight normal mean with respect licensed product first sale third party consumption such licensed product given country following receipt regulatory approval such country provided that first commercial sale shall include sale disposal licensed product marketing regulatory development charitable purpose such clinical trial clinical trial compassionate named patient indigent patient program without consideration font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m name _toc name _ref name _ref name _ref name _dv_m name _toc font style margin left font font style font weight normal font gaap font style font weight normal mean then current generally accepted accounting principle name _dv_m name _toc applied consistent basis font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight normal font font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style font weight normal font font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style font weight normal font font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style font weight normal font font style font weight bold font size font family time roman font style normal text transform none font variant normal good clinical practice font font style font weight normal font font style font weight normal mean then current standard practice procedure promulgated endorsed forth guideline entitled guidance industry good clinical practice consolidated guidance including related regulatory requirement imposed comparable regulatory standard practice procedure promulgated other regulatory authority applicable territory they updated from time time including applicable quality guideline promulgated under font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font font style font weight normal font font style font weight normal font good laboratory practice font style font weight normal mean then current good laboratory practice standard promulgated endorsed defined part comparable regulatory standard promulgated other regulatory authority applicable territory they updated from time time including applicable quality guideline promulgated under font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font font style font weight normal font font style font weight normal font good manufacturing practice font style font weight normal mean then current good manufacturing practice required forth regulation promulgated thereunder manufacture testing pharmaceutical material comparable regulation applicable manufacture testing pharmaceutical material promulgated other regulatory authority they updated from time time font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font governmental authority font style font weight normal mean multinational federal state local municipal provincial other governmental authority nature including governmental division prefecture subdivision department agency bureau branch office commission council court other tribunal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc name _toc name _toc font style margin left font font style font weight normal font font style font weight normal mean international conference harmonisation font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font font style font weight normal font font style font weight normal mean investigational drug application defined applicable regulation promulgated thereunder equivalent application equivalent agency other regulatory jurisdiction filing which necessary initiate conduct clinical trial pharmaceutical product human such jurisdiction font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font indemnified party font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font indemnifying party font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref font style margin left font font style font weight normal font information font style font weight normal mean data result technology business financial information information type whatsoever tangible intangible form including know trade secret practice technique method process development specification formulation formula type kind patentable otherwise software algorithm marketing report expertise technology test data including pharmacological biological chemical biochemical clinical test data data resulting from clinical study chemistry manufacture control font font style font weight normal information stability data other study data procedure font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font font style font weight normal font initiation font style font weight normal clinical trial mean first dosing first subject such clinical trial nbsp nbsp font initiate font style font weight normal font font style font weight normal correlative meaning font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou name _dv_m name _dv_c font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight normal font font style font weight bold font size font family time roman font style normal text transform none font variant normal invention font font style font weight normal name _dv_m name _dv_c meaning forth section font font style font weight normal font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c font style margin left font font style font weight normal font joint collaboration result font style font weight normal mean collaboration result generated jointly behalf both amgen arrowhead their respective affiliate font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font joint invention font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font joint font style font weight normal meaning forth font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font joint patent font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font joint research committee font style font weight normal font font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font font style font weight normal font knowledge font style font weight normal party meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font font style font weight normal mean statute rule regulation ordinance other pronouncement having effect federal national multinational state provincial county city other political subdivision font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _toc name _toc font style margin left font font style font weight normal font licensed compound font style font weight normal mean rnai molecule inhibiting expression collaboration target that provided optimized modified directly from arrowhead research deliverable back rnai molecule thereto that have been generated arrowhead before effective date during term which rnai molecule licensed amgen hereunder font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font licensed product font style font weight normal mean pharmaceutical product containing comprising licensed compound active pharmaceutical ingredient nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m name _dv_m name _dv_m name _toc font style margin left font font style font weight normal font manufacture font style font weight normal mean activity related manufacturing licensed compound licensed product ingredient thereof including test method development stability testing formulation process development manufacturing scale name _dv_m manufacturing licensed compound licensed product bulk finished form development manufacturing finished licensed product commercialization packaging process finished licensed product testing release licensed product component ingredient thereof quality assurance activity related manufacturing release licensed product regulatory activity related foregoing nbsp nbsp font manufacturing font style font weight normal name _dv_m name _toc correlative meaning font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_m font style margin left font font style font weight normal font material font style font weight normal name _dv_c meaning forth section name _dv_m font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m name _dv_m font style margin left font font style font weight normal name _dv_m name _dv_m font sale font style font weight normal mean with respect given period time gross sale licensed product following regulatory approval amgen affiliate sublicensees such period following deduction which actually incurred allowed paid accrued specifically allocated such gross sale amount licensed product using gaap applied consistent basis font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal credit allowance defective damaged licensed product including allowance spoiled outdated withdrawn licensed product return rejection licensed product price adjustment billing error font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight normal governmental font font style font weight normal payment font font style font weight normal other rebate font font style font weight normal refund chargebacks font font style font weight normal equivalent thereof granted managed health care organization pharmacy benefit manager equivalent thereof federal state provincial local other government their agency purchaser reimbursers trade customer font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal normal customary trade cash prompt payment quantity discount allowance credit mandated discount font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal distribution service agreement allowed paid third party distributor reasonable paid wholesaler selling agent excluding sale representative amgen affiliate sublicensees group purchasing organization third party payors other contractees managed care entity each case with respect such licensed product font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal gross sale cover such item transportation cost including insurance outbound freight other transportation charge additional special packaging debt nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal sale value added other other than income duty paid relation such licensed product other equivalent governmental charge imposed upon importation sale licensed product font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal retroactive price reduction third party applicable sale such licensed product font style text align justify margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal sale licensed product between among amgen affiliate sublicensees shall excluded from computation sale subsequent final sale licensed product third party such affiliate sublicensees shall included computation sale style text align justify margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal notwithstanding foregoing event licensed product sold country territory combination product sale combination product will calculated follows style text align justify margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal font style margin left licensed product other active component each sold separately such country sale will calculated multiplying total sale described above combination product fraction where average gross selling price such country licensed product sold separately same formulation dosage average gross selling price such country such other active component sold separately same formulation dosage during applicable calendar font quarter sale both licensed product other product occur such period then most recent royalty reporting period which such separate sale both such licensed product other product occurred nbsp nbsp style text align justify margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style margin left licensed product sold independently other active component therein such country average selling price such other active component determined sale will calculated multiplying total sale described above combination product fraction where font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin margin left font size font family time roman font weight normal font style normal text transform none font variant normal font style font size font family time roman font weight normal font style normal text transform none font variant normal average selling price such country such licensed product sold independently average selling price such country entire combination product font style text align justify margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal font style margin left licensed product font sold independently such country party shall determine sale such combination product mutual agreement based relative contribution licensed product other active ingredient combination product style text align justify margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal discount allowance credit rebate other deduction shall fairly allocated licensed product between licensed product other product service amgen affiliate sublicensees shall inappropriately allocated nbsp nbsp amgen shall attempt reduce compensation rightly arrowhead hereunder shifting compensation otherwise payable amgen from third party with respect licensed product another product service which royalty payable hereunder style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font breaching party font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font option font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font option period font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font party font style font weight normal meaning forth introductory paragraph font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m name _toc font style margin left font font style font weight normal font patent font style font weight normal font font style font weight normal mean font font style font weight normal name _dv_m name _toc pending patent application issued patent utility model design reissue substitution confirmation registration validation examination addition continuation continued prosecution application continuation part division foregoing extension renewal restoration foregoing existing future extension renewal restoration mechanism including supplementary protection certificate equivalent thereof font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font phase clinical trial font style font weight normal mean clinical trial licensed product field conducted patient with disease condition under study evaluate effectiveness licensed product extent defined amended from time time equivalent regulation regulatory jurisdiction outside font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font phase clinical trial font style font weight normal mean pivotal clinical trial licensed product field with defined dose defined such licensed product sufficient number human patient designed confirm with statistical significance safety efficacy such licensed product support regulatory approval extent defined amended from time time equivalent regulation regulatory jurisdiction outside font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc name _toc name _aeioulastrenderedpagebreakaeiou name _dv_m font style margin left font font style font weight normal font regulatory approval font style font weight normal font font style font weight normal mean approval from relevant regulatory authority given country regulatory jurisdiction regulatory approval application licensed product field including license registration pricing reimbursement approval that necessary sale marketing such licensed product including font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal name _dv_m clinical testing manufacture distribution such licensed product such country regulatory jurisdiction font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font regulatory approval application font style font weight normal mean application appropriate regulatory authority approval sell licensed product particular jurisdiction including font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font regulatory authority font style font weight normal mean particular country jurisdiction applicable governmental authority that authority regulate manufacture marketing testing pricing sale drug product such country jurisdiction font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font font style font weight normal font regulatory exclusivity font style font weight normal mean exclusive marketing right data exclusivity right conferred governmental authority under applicable with respect licensed product country jurisdiction territory prevent third party from commercializing such licensed product such country jurisdiction other than patent right including orphan drug exclusivity pediatric exclusivity right conferred under hatch waxman modernization under directive right similar thereto other country regulatory jurisdiction territory font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font regulatory material font style font weight normal mean regulatory application submission notification communication correspondence registration regulatory approval other filing made received from otherwise conducted with regulatory authority order develop manufacture commercialize licensed product particular country jurisdiction font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font research plan font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font research plan outline font style font weight normal mean outline research plan forth font font style text decoration underline font weight normal exhibit font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m font style margin left font font style font weight normal font research program font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m font style margin left font font style font weight normal font research term font style font weight normal mean period commencing effective date ending earlier occur delivery arrowhead research deliverable arrowhead amgen date that twenty four month following effective date name _dv_m font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font rnai molecule font style font weight normal mean exogenous double stranded oligomeric modified variant thereof molecule incorporating acetyl galactosamine galnac ligand conjugate capable binding asialoglycoprotein receptor asgpr enhance targeting liver nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font royalty term font style font weight normal meaning forth section name _dv_m font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font second collaboration agreement font style font weight normal mean that certain second collaboration license agreement entered into between arrowhead amgen even date herewith font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font stock purchase agreement font style font weight normal meaning forth recital font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight normal font font style font weight bold font size font family time roman font style normal text transform none font variant normal subject patent font font style font weight normal meaning forth section font font style font weight normal font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font sublicensee font style font weight normal meaning forth section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal font target font style font weight normal mean polypeptide entity comprising combination least polypeptide other macromolecule that site potential site therapeutic intervention therapeutic agent variant polypeptide including splice variant thereof cellular entity nucleic acid described clause defined peptide entity including microorganism virus bacterium single cell parasite provided that entire genome virus shall regarded single target nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m name _toc font style margin left font font style font weight normal font term font style font weight normal meaning forth section name _dv_m name _toc font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m font style margin left font font style font weight normal font territory font style font weight normal name _dv_m mean country world font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font font style font weight normal font third party font style font weight normal mean entity other than arrowhead amgen affiliate either them font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_c font style margin left font font style font weight normal font font style font weight normal name _dv_c mean united state america including possession territory thereof font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal font valid claim font style font weight normal font font style font weight normal mean issued claim that expired been revoked canceled been declared invalid unenforceable patent office decision court other governmental authority competent jurisdiction provided that such claim that been declared invalid unenforceable subsequently determined valid enforceable court other governmental authority competent jurisdiction from which appeal taken taken within allowable time period then such claim shall thereafter valid claim except otherwise provided under subsection been admitted invalid unenforceable through reissue examination disclaimer otherwise been abandoned disclaimed font style text align center margin bottom margin text indent font weight bold text transform uppercase font size font family time roman font style normal font variant normal name _dv_m name _ref article font style font weight normal text transform none name _ref font font style text transform none research program font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc name _ref name _toc name _dv_m font style margin left font overview font style font weight normal nbsp nbsp pursuant this agreement further described this article article font font style font weight normal hereof arrowhead will conduct research program identify optimize rnai molecule capable inhibiting expression collaboration target field under direction oversight accordance with research plan font research program font style font weight normal nbsp nbsp during research term arrowhead shall prepare deliver amgen arrowhead research deliverable time during option period amgen exercise option further develop commercialize licensed product under license from arrowhead provided article name _dv_m font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _dv_m name _dv_m name _dv_m font style margin left font governance font style font weight normal nbsp nbsp party activity during research term will directed overseen joint research committee formed under operated accordance with article this agreement font joint research committee font style font weight normal font font style font weight normal name _dv_m name _dv_m name _dv_m nbsp nbsp font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight bold font size font family time roman font style normal text transform none font variant normal arrowhead responsibility font font style font weight normal nbsp nbsp during research term arrowhead shall commercially reasonable effort conduct activity assigned pursuant this article font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m font style margin left font amgen responsibility font style font weight normal nbsp nbsp during research term amgen shall conduct those name _dv_m activity necessary amgen determine sole discretion whether exercise option pursuant section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font expense font style font weight normal nbsp nbsp except otherwise expressly provided this article article name _dv_m each party will bear expense incurs conduct activity during research term font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _ref name _toc name _dv_m name _dv_m name _dv_c font style margin left font data exchange font style font weight normal nbsp nbsp reasonably promptly following effective date arrowhead will provide name _dv_m amgen with reasonably detailed summary arrowhead name _dv_m research existing effective date nbsp nbsp during research term arrowhead shall provide update such summary amgen least quarterly nbsp nbsp upon reasonable request arrowhead will provide amgen with electronic copy portion arrowhead research requested name _dv_c amgen notwithstanding anything this agreement contrary arrowhead decline share with amgen portion arrowhead research arrowhead determines that doing would reasonably expected have material adverse effect arrowhead research nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _ref name _dv_x name _dv_c name _dv_c font style margin left font collaboration result font style font weight normal name _dv_x name _dv_c subject term condition this agreement arrowhead name _dv_c will arrowhead collaboration result amgen will amgen collaboration result each party will jointly joint collaboration result nbsp nbsp except otherwise provided this agreement each party shall have right exploit joint collaboration result purpose without duty accounting seeking consent from other party nbsp nbsp each party shall notify other party promptly after developing collaboration result which other party owner nbsp nbsp each party shall assign hereby assigns other party entire right title interest collaboration result intellectual property right therein needed implement ownership collaboration result accordance with provision this section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref font style margin left font record report font style font style italic font weight normal nbsp nbsp font font style font weight normal each party shall maintain reasonably complete accurate record form technical notebook electronic file where appropriate work conducted under research program information resulting from such work nbsp nbsp such record including electronic file where such information also contained shall reasonably reflect work done result achieved performance research program sufficient detail good scientific manner appropriate patent regulatory purpose shall stored manner that allows maintaining party access such record reasonably timely manner nbsp nbsp upon party reasonable request subject section such party shall have right review copy such record maintained other party reasonable time obtain access reasonably timely manner original extent needed patent regulatory purpose other legal proceeding nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _ref name _aeioulastrenderedpagebreakaeiou name _dv_m name _dv_m name _dv_m name _dv_c name _dv_m name _dv_m font style margin left font material transfer font style font weight normal nbsp nbsp facilitate conduct research program either party provide other party certain biological material chemical compound owned licensed supplying party other party furtherance research program such material compound provided hereunder referred collectively font material font style font weight normal nbsp nbsp font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal except otherwise expressly provided under this agreement such material delivered other party shall remain sole property supplying party shall used only furtherance font font style font weight normal exercise right performance obligation under this agreement accordance with this agreement font font style font weight normal solely under control other party shall used delivered benefit third party without prior written consent supplying party shall used research testing involving human subject font font style font weight normal animal intended food each case unless otherwise specifically contemplated hereunder will used compliance with applicable rule regulation font font style font weight normal nbsp nbsp font font style font weight normal provision material receiving font font style font weight normal font font style font weight normal arty hereunder grant such font font style font weight normal font font style font weight normal arty right other than those specifically granted this agreement nbsp nbsp delivery material shall font font style font weight normal font font style font weight normal incoterms font font style font weight normal nbsp nbsp font font style font weight normal nbsp nbsp font font style font weight normal receiving font font style font weight normal font font style font weight normal arty shall responsible consent approval authorization other permit necessary handling transfer storage material nbsp nbsp receiving font font style font weight normal font font style font weight normal arty shall receive material promptly notify supplying font font style font weight normal font font style font weight normal arty when material have been received forward supplying font font style font weight normal font font style font weight normal arty applicable chain custody form transport temperature record receipt verification documentation such other documentation reasonably requested supplying font font style font weight normal font font style font weight normal arty nbsp nbsp receiving font font style font weight normal font font style font weight normal name _dv_m arty shall responsible import clearance including preparing necessary documentation with respect thereto making entry shipment nbsp nbsp font font style font weight normal supplying font font style font weight normal font font style font weight normal name _dv_m arty shall provide relevant shipping documentation forma invoice airway bill together with such other documentation necessary handling transfer storage material font font style font weight normal name _dv_m nbsp nbsp font font style font weight normal material supplied under this font font style font weight normal section font font style font weight normal font font style font weight normal supplied font font style font weight normal must used with prudence appropriate caution experimental work font font style font weight normal font font style font weight normal font font style font weight normal since font font style font weight normal name _dv_c their characteristic known nbsp nbsp except expressly forth herein material without representation warranty express implied including implied warranty merchantability fitness particular purpose warranty that material will infringe violate patent other proprietary right third party nbsp nbsp font font style font weight normal during research font font style font weight normal term font font style font weight normal name _dv_m font font style font weight normal record keeping purpose font font style font weight normal font font style font weight normal arties shall compile list that shall include type material quantity shipping date other relevant detail quarterly basis setting forth material provided from each font font style font weight normal font font style font weight normal arty which document shall signed authorized representative each font font style font weight normal font font style font weight normal name _dv_m arty font font style font weight normal font font style font weight normal nbsp nbsp clarity this section font font style font weight normal font font style font weight normal font font style font weight normal shall apply during research font font style font weight normal term font font style font weight normal only after which font font style font weight normal font font style font weight normal arties will enter into appropriate material transfer agreement with respect transfer material which agreement will subject this agreement will interpreted consistent with term hereof font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _toc name _dv_c name _dv_m font style margin left font subcontracting font style font weight normal nbsp nbsp each party perform research program obligation under this agreement through more subcontractor consultant provided that subcontracting party remains responsible work allocated payment such subcontractor consultant selects same extent would done such work itself subcontractor undertakes writing obligation confidentiality regarding confidential information that restrictive than those undertaken party pursuant article hereof name _dv_c name _dv_m subcontractor agrees writing assign intellectual property developed course performing such work under research program party retaining such subcontractor nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _dv_c name _dv_m name _aeioulastrenderedpagebreakaeiou name _dv_m font style margin left font disclaimer font style font weight normal font font style color font weight normal name _dv_c without limiting generality warranty disclaimer forth section font font style font weight normal name _dv_m font font style color font weight normal arrowhead disclaims warranty with regard success activity font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style color font weight normal conducted under research program font font style color font weight normal safety usefulness purpose font font style color font weight normal compound font font style color font weight normal name _dv_m provided discovered under this agreement font font style color font weight normal font style text align center margin bottom margin text indent font weight bold text transform uppercase font size font family time roman font style normal font variant normal name _dv_m name _ref name _toc article font style text transform none name _ref name _toc exclusivity related restriction font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _dv_m font style margin left font exclusivity font style font weight normal name _dv_m nbsp nbsp during term arrowhead affiliate shall conduct participate advise assist enable third party conduct participate research development manufacture commercialization compound directed collaboration target nbsp nbsp amgen exercise option pursuant section option exercise pursuant section amgen shall have acquired from arrowhead exclusive access collaboration target during term thereafter arrowhead affiliate shall conduct participate advise assist enable third party conduct participate research development manufacture commercialization compound directed collaboration target font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m name _dv_m name _dv_c name _dv_m name _dv_c name _dv_m name _dv_c name _dv_m name _dv_m font style margin left font change control font style font weight normal nbsp nbsp notwithstanding anything contrary this agreement event change control arrowhead successor entity thereto applying definition change control such successor place arrowhead occurring after exercise amgen option subject section section name _dv_c shall apply otherwise restrict name _dv_m activity acquiror affiliate except arrowhead affiliate prior acquisition with respect product product candidate device being clinically developed commercialized prior date acquisition name _dv_c name _dv_m including making using selling offering sale importing otherwise developing commercializing exploiting thereof name _dv_c intellectual property right name _dv_m controlled such acquiror affiliate other than arrowhead affiliate prior acquisition related thereto provided that such product product candidate device name _dv_m service developed through information intellectual property right controlled arrowhead acquisition affiliate date such change control thereafter nbsp nbsp arrowhead shall give amgen written notice within five after public announcement disclosure proposed change control arrowhead nbsp nbsp from after such notice amgen shall have right transfer some research program activity from arrowhead amgen upon written notice amgen exclude arrowhead following such change control from participation whole part from working team shall longer subject obligation forth section section shall required share correspondence filing other information with arrowhead discus with arrowhead consider comment either case with respect intellectual property matter forth article nbsp nbsp event change control arrowhead acquiror itself through affiliate directly indirectly conduct participates competing program acquiror shall hold separate such competing program including ensuring that personnel working licensed compound licensed product activity hereunder work competing program vice versa ensuring that information material relating licensed compound licensed product activity hereunder shared with used benefit sequestered from personnel working competing program vice versa font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _aeioulastrenderedpagebreakaeiou font style margin left font amgen target related confidential information font style font weight normal during term thereafter neither arrowhead affiliate shall reference advise assist font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal enable third party reference font font style font weight normal font font style font weight normal font font style font weight normal such font font style font weight normal font font style font weight normal background font font style font weight normal amgen font font style font weight normal font font style font weight normal font font style font weight normal confidential font font style font weight normal information font font style font weight normal amgen font font style font weight normal disclosed amgen arrowhead before during term font font style font weight normal intellectual property font font style font weight normal information font font style font weight normal generated font font style font weight normal party font font style font weight normal research program hereunder font font style font weight normal font font style font weight normal solely jointly behalf party their affiliate font font style font weight normal research development manufacture commercialization font font style font weight normal font font style font weight normal font font style font weight normal compound font font style font weight normal directed font font style font weight normal font font style font weight normal font font style font weight normal except font font style font weight normal performing obligation under font font style font weight normal this agreement font font style font weight normal nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m font style margin left font collaboration result font style font weight normal nbsp nbsp arrowhead shall publicly disclose collaboration result without express written consent amgen which consent granted withheld amgen sole discretion name _dv_m nbsp nbsp font style text align center margin bottom margin text indent font weight bold text transform uppercase font size font family time roman font style normal font variant normal name _dv_m name _ref article font style font weight normal text transform none name _ref font font style text transform none option license font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref font style margin left font research license font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _ref name _dv_m font style margin left font font style font weight normal subject term condition this agreement arrowhead hereby grant amgen during research term nonexclusive worldwide royalty free license with right sublicense solely provided section under arrowhead research extent necessary reasonably useful amgen solely name _dv_m conduct activity described under article connection with performance research program accordance with term this agreement conduct those activity necessary amgen determine sole discretion whether exercise option pursuant section provided however amgen shall permitted conduct enabling study under license from arrowhead provided this section nbsp nbsp notwithstanding anything contrary this agreement arrowhead agrees supply amgen cost with such material amgen reasonably require carry activity contemplated clause this section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal subject term condition this agreement amgen hereby grant arrowhead during research term nonexclusive worldwide royalty free license with right sublicense solely provided section under patent information controlled amgen solely extent necessary reasonably useful arrowhead solely conduct activity under research program accordance with term this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc name _ref name _dv_m name _dv_m font style margin left font option font style font weight normal name _dv_m nbsp nbsp arrowhead hereby grant amgen exclusive option obtain exclusive license forth section font option font style font weight normal nbsp nbsp such option will expire then exercised anniversary expiration research term extended font option period font style font weight normal amgen exercise name _dv_m such option written notice arrowhead prior expiration option period nbsp nbsp such event amgen will arrowhead option exercise under section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font option extension font style font weight normal nbsp nbsp prior option period amgen right extend option period additional period notifying arrowhead thereof writing provided however that amgen only right extend option period total time nbsp nbsp each extension option period pursuant this section amgen will arrowhead option extension under section font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _aeioulastrenderedpagebreakaeiou name _dv_m name ole_link name ole_link font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight bold font size font family time roman font style normal text transform none font variant normal license font font style font weight bold font size font family time roman font style normal text transform none font variant normal amgen font font style font weight normal name _dv_m name ole_link name ole_link font font style font weight normal nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font arrowhead developed font style font weight normal nbsp nbsp subject term condition this agreement upon amgen exercise option accordance with section arrowhead receipt option exercise arrowhead shall grant amgen exclusive even arrowhead except provided section royalty bearing license with right sublicense solely provided section under arrowhead licensed technology with respect licensed compound licensed product arrowhead right under joint make have made sell offer sale import otherwise exploit such licensed compound licensed product territory nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font arrowhead background font style font weight normal nbsp nbsp subject term condition this agreement upon amgen exercise option accordance with section arrowhead receipt option exercise arrowhead shall grant amgen exclusive license with right sublicense solely provided section under arrowhead background with respect licensed compound licensed product make have made sell offer sale import otherwise exploit such licensed compound licensed product nbsp nbsp territory font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref font style margin left font arrowhead retained right font style font weight normal nbsp nbsp except expressly granted under section limited article arrowhead retains right under arrowhead licensed technology territory fulfill obligation under this agreement exploit arrowhead licensed technology joint other than connection with compound directed collaboration target licensed compound licensed product arrowhead know connection with arrowhead conduct general research discovery molecule other than compound directed collaboration target licensed compound licensed product provided that activity permitted under this subsection permitted article font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font sublicense right subcontracting style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font font style font weight normal amgen shall have right grant sublicense license granted section affiliate third party whether directly through multiple tier accordance with term subsection below each font sublicensee font style font weight normal provided that amgen report identity third party sublicensee arrowhead within thirty granting such sublicense provided further that sublicenses third party shall subject section through font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal amgen shall remain primarily responsible performance obligation hereunder failure sublicensees comply with applicable term this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal such sublicense shall refer this agreement shall conflict with amgen obligation hereunder font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style margin left font font style font weight normal within reasonable time after execution such sublicense amgen shall provide arrowhead copy such sublicense which redacted omit term font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal relevant determining font font style font weight normal amgen font font style font weight normal such sublicensee obligation under this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal except otherwise provided sublicense this agreement terminates reason upon amgen written request arrowhead sublicensee license forth section shall from effective date such termination automatically become direct licensee arrowhead term condition hereunder with respect right licensed amgen sublicensed sublicensee amgen nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal such sublicensees license contained section shall have right grant further sublicenses third party same lesser scope sublicense from amgen under license contained section provided that such further sublicenses shall accordance with subject term condition this section such sublicensee shall subject this section same manner same extent amgen nbsp nbsp clarity person entity whom sublicensee grant sublicense permitted term this agreement shall deemed sublicensee purpose this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal amgen shall have right retain third party contractor perform activity connection with amgen exercise right granted under section section where such activity performed direction control sole benefit amgen affiliate sublicensees nbsp nbsp such retention third party contractor shall sublicense within meaning this section shall considered activity amgen under license granted section section applicable font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font implied license font style font weight normal nbsp nbsp except explicitly forth this agreement neither party shall deemed estoppel implication have granted other party license other right intellectual property such party font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font expiration right amgen collaboration result font style font weight normal nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal clarity upon expiration option period including extension thereto amgen exercised option will have further right collaboration result except amgen collaboration result joint collaboration result font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _dv_m name _dv_m font style margin left font font style font weight normal reasonably promptly following expiration option period amgen exercised option amgen will provide arrowhead with reasonably detailed summary joint collaboration result derived possession amgen nbsp nbsp upon reasonable request arrowhead amgen will reasonably promptly provide arrowhead with electronic copy portion amgen collaboration result described such summary name _dv_m name _dv_m nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m name _dv_m name _dv_c font style margin left font contractor font style font weight normal nbsp nbsp extent that party contract with third party contractor perform service hereunder shall term that commercially reasonable including name _dv_c with respect confidentiality intellectual property right font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align center margin bottom margin text indent font weight bold text transform uppercase font size font family time roman font style normal font variant normal name _dv_m name _aeioulastrenderedpagebreakaeiou name _ref font style font weight bold text transform uppercase font size font family time roman font style normal font variant normal article font font style text transform none name _ref font font style text transform none governance font font style text transform none research plan font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref font style margin left font joint research committee font style font weight normal nbsp nbsp joint research committee established pursuant this article will have oversight responsibility overall review research activity pursuant subject term condition this agreement during research term nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font formation purpose font style font weight normal within after effective date party shall promptly establish convene accordance with section that will direct oversee research activity during research term under this agreement nbsp nbsp shall consist representative from arrowhead amgen operate accordance with procedure forth section other procedure agreed upon member nbsp nbsp except otherwise provided herein role joint research committee shall font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal encourage facilitate ongoing communication cooperation between party with respect research activity during research term under this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal review discus approve appropriate research plan proposed amendment revision such research plan font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal establish other such working group subcommittee needed further purpose agreement relating licensed compound licensed product mutually agreed party writing font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal resolve dispute referred font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal approve decide such other matter provided this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font decision final decision authority font style font weight normal margin left will make good faith effort make decision consensus nbsp nbsp except forth this section font font style font weight normal action taken joint research committee shall taken only following unanimous vote with each party representative collectively having vote nbsp nbsp joint research committee fails reach unanimous agreement matter before decision period excess fifteen from date first presented writing either party submit such matter resolution executive officer party attempted resolution good faith negotiation after such notice received among executive officer nbsp nbsp event that such executive officer unable reach agreement regarding matter referred them then decision relates solely collaboration target decision will made amgen unless such decision would reasonably expected have material adverse effect arrowhead research which case decision will made arrowhead decision relates solely arrowhead research decision will made arrowhead font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font discontinuation font style font weight normal nbsp nbsp upon expiration research term shall discontinued font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight bold font size font family time roman font style normal text transform none font variant normal membership font font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style font weight normal nbsp nbsp font font style font weight normal arrowhead amgen shall each designate equal number representative serve written notice other party nbsp nbsp promptly after effective date each party shall designate three representative nbsp nbsp elect vary number representative from time time during term provided that shall maintain equal number representative from each party nbsp nbsp each representative shall have appropriate level experience subject area least representative shall have sufficient seniority within applicable party organization have necessary decision making authority order fulfill responsibility nbsp nbsp either party designate substitute representative more such party designated representative unable present meeting nbsp nbsp from time time each party replace representative written notice other party specifying prior representative their replacement nbsp nbsp discretion create functional subcommittee working team font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font chairperson font style font weight normal will have chairperson designated each party nbsp nbsp chairperson shall responsible calling convening meeting shall have special authority over other member shall have additional voting right nbsp nbsp chairperson their designates shall jointly prepare circulate agenda reasonably advance each upcoming meeting prepare issue minute each meeting promptly practicable thereafter nbsp nbsp such minute shall finalized until each representative review approves such minute writing font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font meeting style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font meeting font style font weight normal nbsp nbsp shall meet least once each calendar quarter such other frequency shall agreed member nbsp nbsp additional meeting held with consent each party such consent unreasonably withheld conditioned delayed required under this agreement nbsp nbsp case dispute referred such meeting shall held soon reasonably possible following referral nbsp nbsp addition they mutually agree party hold joint meeting governance body established under second collaboration agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font general requirement font style font weight normal nbsp nbsp meeting shall effective only majority representative each party present participating nbsp nbsp other than initial meeting which shall held person meet either person either party facility such location party otherwise agree audio video teleconference nbsp nbsp additional member representative party having relevant experience from time time invited participate meeting provided that such participant shall have voting right power nbsp nbsp member participant employee party affiliate shall only allowed attend other party representative have consented attendance such member participant subject confidentiality obligation least restrictive those forth this agreement nbsp nbsp each party shall responsible expense incurred connection with participating including travel expense associated with initial alliance kick meeting nbsp nbsp other expense incurred furtherance meeting such expense associated with site meeting shall shared equally party font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _toc name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight bold font size font family time roman font style normal text transform none font variant normal alliance manager font font style font weight normal nbsp nbsp promptly following effective date each party shall designate writing alliance manager serve primary point contact party regarding collaboration transition activity contemplated under this agreement nbsp nbsp each alliance manager shall facilitate communication coordination party activity under this agreement relating product shall plan meeting font font style font weight normal nbsp nbsp alliance manager shall allowed attend meeting voting observer font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font authority font style font weight normal nbsp nbsp shall have only power assigned expressly this article elsewhere this agreement shall have power amend modify waive compliance with this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _ref font style margin left font name _ref research plan font style font weight normal during research term shall agree upon oversee reasonably detailed written research plan font research plan font style font weight normal concerning research conducted during research term consistent with research plan outline nbsp nbsp subject accordance with this article upon exercise option amgen shall solely responsible research development licensed compound licensed product field accordance with applicable nbsp nbsp nbsp nbsp nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font cost font style font weight normal nbsp nbsp each party shall responsible cost conducting activity under research program nbsp nbsp font style text align center margin bottom margin text indent font weight bold text transform uppercase font size font family time roman font style normal font variant normal name _dv_m name _toc name _ref name _dv_m article font style text transform none name _ref font font style font family time roman bold name _dv_m regulatory font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font regulatory responsibility font style font weight normal nbsp nbsp accordance with this article following exercise option amgen shall solely responsible expense preparing filing maintaining regulatory material licensed product with regulatory authority related licensed product territory amgen shall regulatory material including inds ndas regulatory approval application regulatory approval licensed product territory otherwise shall responsible regulatory matter with respect licensed product territory font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font regulatory matter font style font weight normal nbsp nbsp following exercise option amgen shall keep arrowhead reasonably informed material regulatory development relating licensed product territory through annual development report under section font style text align center margin bottom margin text indent font weight bold text transform uppercase font size font family time roman font style normal font variant normal name _dv_m name _toc article font style text transform none font font style font family time roman bold development commercialization font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc name _aeioulastrenderedpagebreakaeiou font style margin left font general font style font weight normal nbsp nbsp following exercise option amgen itself with affiliate sublicensees will solely responsible expense aspect development commercialization licensed compound licensed product territory nbsp nbsp clarity after research term prior exercise option pursuant section payment option pursuant section expiration option period case amgen shall have right conduct preclinical development with respect licensed compound licensed product extent permitted under section nbsp nbsp subject express written term this agreement decision concerning development marketing sale licensed product including clinical regulatory strategy design font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal sale price promotion licensed product under this agreement shall within sole discretion amgen font font style font weight normal nbsp nbsp following exercise option arrowhead will promptly transfer amgen arrowhead know reasonably necessary useful amgen develop seek regulatory approval licensed compound licensed product including material supporting regulatory filing consistent with amgen obligation under article font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font diligence font style font weight normal nbsp nbsp following exercise option amgen shall commercially reasonable effort develop seek regulatory approval successful commercialize licensed product more field territory font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font communication font style font weight normal nbsp nbsp during term until licensed product receives regulatory approval amgen shall provide arrowhead summary once calendar year material development with respect licensed product including anticipated timing completion process clinical trial result phase clinical trial estimate progress towards meeting milestone that expected achieved within following month regulatory approval licensed product territory received manufacturing information pursuant section this agreement nbsp nbsp report other information provided amgen under this section will amgen confidential information subject term article font style text align center margin bottom margin text indent font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal name _dv_m name _toc name _toc name _toc name _dv_c article font style font family time roman text transform none font name _dv_c manufacture supply style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font responsibility font style font weight normal nbsp nbsp except otherwise expressly provided this article between party following exercise option amgen will solely responsible manufacture licensed compound licensed product expense development commercialization purpose territory nbsp nbsp promptly following exercise option amgen arrowhead will transfer amgen relevant manufacturing process arrowhead know reasonably necessary useful amgen third party manufacturer manufacture licensed compound licensed product including material supporting regulatory filing nbsp nbsp such manufacturing process transferred arrowhead amgen shall similar quality process used arrowhead internal compound product similar stage development applicable intended following exercise option amgen upon request amgen party shall negotiate good faith enter into agreement under which arrowhead would provide process development manufacturing service amgen customary term condition including financial term consistent with market practice font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font third party manufacture font style font weight normal nbsp nbsp amgen perform manufacture licensed compound licensed product through more third party manufacturer provided that amgen remains responsible such third party manufacturer performing activity under this agreement unauthorized such third party manufacturer arrowhead licensed technology provided amgen third party manufacturer undertakes writing obligation confidentiality regarding confidential information that protective than those forth article third party manufacturer agrees writing commercially reasonable term with respect intellectual property relating such licensed compound licensed product font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight bold font size font family time roman font style normal text transform none font variant normal manufacturing cooperation font font style font weight normal nbsp nbsp following exercise option font font style font weight normal amgen arrowhead shall each keep other party font font style font weight normal reasonably informed font font style font weight normal identity third party manufacturer performing font font style font weight normal manufacturing activity licensed compound licensed product font font style font weight normal case amgen font font style font weight normal through annual development report under section font font style font weight normal font font style font weight normal once licensed font font style font weight normal product font font style font weight normal receives regulatory approval through annual update communicated through alliance manager font font style font weight normal font font style font weight normal font font style font weight normal nbsp nbsp following exercise option arrowhead shall keep amgen reasonably informed material improvement made affiliate third party manufacturer manufacturing process rnai molecule through periodic update communicated through alliance manager font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _ref name _toc font style margin left font manufacturing information font style font weight normal nbsp nbsp amgen affiliate third party manufacturer shall arrowhead know related manufacture licensed compound licensed product accordance with license granted section only purpose manufacturing licensed compound licensed product nbsp nbsp prior transfer arrowhead know that confidential information third party manufacturer amgen shall require that such third party bound confidentiality restriction least protective aggregate those article name _dv_m name _ref name _ref name _toc font style text align center margin bottom margin text indent font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal name _dv_m name _toc name _ref article font style font family time roman text transform none name _ref font compensation style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font upfront payment font style font weight normal nbsp nbsp within after effective date amgen shall arrowhead time refundable creditable upfront payment five million dollar nbsp nbsp amgen shall also purchase initial closing share pursuant section stock purchase agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _toc name _toc font style margin left font option exercise font style font weight normal nbsp nbsp upon exercise option amgen shall arrowhead time refundable creditable option exercise payment dollar nbsp nbsp amgen shall also purchase third tranche share defined pursuant section stock purchase agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _ref font style margin left font option extension font style font weight normal nbsp nbsp upon extension option period pursuant section amgen shall arrowhead additional dollar each such extension nbsp nbsp event shall amgen obligated more than dollar extension more than dollar aggregate four extension permitted under section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_m font style margin left font name _dv_m research development cost font style font weight normal nbsp nbsp each party shall responsible cost conducting research development activity under research program accordance with section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font development regulatory milestone payment nbsp nbsp font style font weight normal amgen shall make each following time refundable creditable development regulatory milestone payment arrowhead upon achievement amgen affiliate sublicensees applicable development milestone event licensed product nbsp nbsp amgen shall arrowhead each such amount within after achievement applicable development regulatory milestone event nbsp nbsp font align left table border cellspacing cellpadding style border collapse collapse margin left width table style text align center margin margin bottom margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin margin left text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal confidential font style page break after always width style text align right margin bottom margin margin left text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp align left table border cellspacing cellpadding style border collapse collapse margin left width style width style width style width style width valign style text align center margin bottom margin margin left text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal development font font style font weight bold font size font family time roman font style normal text transform none font variant normal regulatory font font style font weight bold font size font family time roman font style normal text transform none font variant normal milestone event font valign style text align center margin bottom margin margin left text indent font weight bold font size font family time roman font style normal text transform none font variant normal development regulatory milestone payment each paid time only table style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal name _ref style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font commercial milestone nbsp nbsp font style font weight normal amgen shall make each following time refundable except forth section creditable sale milestone payment arrowhead when sale licensed product territory first reach amount specified below nbsp nbsp amgen shall arrowhead such amount within after calendar quarter which such commercial milestone event achieved nbsp nbsp font align left table border cellspacing cellpadding style border collapse collapse margin left width style width style width valign style text align center margin bottom margin margin left text indent font weight bold font size font family time roman font style normal text transform none font variant normal sale milestone event valign style text align center margin bottom margin margin left text indent font weight bold font size font family time roman font style normal text transform none font variant normal milestone payment table style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal name _ref style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font royalty style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font royalty rate font style font weight normal nbsp nbsp subject section amgen shall arrowhead creditable refundable except forth section royalty annual sale licensed product territory calculated multiplying applicable royalty rate corresponding amount incremental sale licensed product territory each calendar year follows font align left table border cellspacing cellpadding style border collapse collapse margin left width style width style width valign style margin bottom margin margin left text indent font weight bold font size font family time roman font style normal text transform none font variant normal annual font style font weight normal font sale licensed product territory valign style margin bottom margin margin left text indent font weight bold font size font family time roman font style normal text transform none font variant normal royalty rate table style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font royalty term nbsp nbsp font style font weight normal royalty shall paid under this section country country basis nbsp nbsp following royalty term amgen shall have fully paid irrevocable freely transferable sublicensable license such country under relevant arrowhead patent make have made sell offer sale import otherwise exploit such licensed product territory font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _ref font style margin left font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font royalty report payment font style font weight normal nbsp nbsp within sixty following each calendar quarter commencing with calendar quarter which first commercial sale licensed product made anywhere territory amgen shall provide arrowhead with report containing following information applicable calendar quarter amount gross sale licensed product territory itemized calculation sale territory calculation royalty payment such sale exchange rate such country nbsp nbsp concurrent with delivery applicable quarterly report amgen shall dollar amount arrowhead pursuant section such calendar quarter font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _ref name _ref name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font blocked currency font style font weight normal nbsp nbsp each country territory where local currency blocked removed from country election amgen royalty accrued sale such country shall paid arrowhead local currency deposit local bank such country designated arrowhead font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font currency payment font style font weight normal nbsp nbsp unless otherwise forth this agreement agreed party payment under this agreement shall made dollar wire transfer immediately available fund into account designated arrowhead nbsp nbsp sale outside shall first determined currency which they earned shall then converted into amount dollar using amgen customary usual conversion procedure used preparing financial statement pursuant gaap applicable reporting period font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font late payment font style font weight normal nbsp nbsp arrowhead receive payment before date then portion thereof hereunder which paid date such payment under this agreement will bear interest lower font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style margin left font record audit font style font weight normal nbsp nbsp amgen affiliate will amgen will cause each sublicensees maintain complete accurate record sufficient detail confirm accuracy calculation royalty payment achievement milestone event period after calendar year which such sale event occurred nbsp nbsp upon reasonable prior notice without disruption amgen business such record amgen affiliate shall made available during regular business hour period from calendar year which they pertain examination more often than once each calendar year independent certified public accountant selected arrowhead reasonably acceptable amgen sole purpose only extent necessary verifying accuracy financial report furnished amgen pursuant this article nbsp nbsp such independent accountant shall disclose arrowhead only amount that such independent accountant belief payable hereunder arrowhead detail concerning discrepancy from amount paid amount shall disclose other information revealed such audit nbsp nbsp record particular calendar year shall only subject audit hereunder nbsp nbsp record examined such independent accountant shall deemed amgen confidential information which disclosed such independent accountant third party amgen require such independent accountant enter into appropriate written agreement obligating bound obligation confidentiality restriction such confidential information that protective than those forth article nbsp nbsp result inspection book record amgen shown that payment under this agreement were than amount which should have been paid then amgen shall make payment required made from original date eliminate discrepancy revealed such inspection within nbsp nbsp result inspection book record amgen shown that payment under this agreement were more than amount which should have been paid then arrowhead shall amgen election either make payment required made eliminate discrepancy revealed such inspection within credit such amount amgen against future payment nbsp nbsp arrowhead shall such audit except that event that audited amount were underpaid amgen more than font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal undisputed amount that should have been paid during period question audit font font style font weight normal amgen font font style font weight normal shall cost audit font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font income font style font weight normal nbsp nbsp each party shall solely responsible payment imposed share income arising directly indirectly from effort party under this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font cooperation font style font weight normal nbsp nbsp party agree cooperate with another reasonable effort reduce eliminate withholding similar obligation respect royalty milestone payment other payment made amgen arrowhead under this agreement nbsp nbsp extent amgen required under internal revenue code amended font code font style font weight normal other deduct withhold payment arrowhead amgen shall amount such proper governmental authority timely manner promptly transmit arrowhead official certificate other evidence such withholding sufficient enable arrowhead claim such payment nbsp nbsp except otherwise provided section deducted withheld such deducted withheld amount shall treated purpose this agreement having been paid arrowhead upon amgen reasonable request arrowhead shall provide amgen form including internal revenue service form other applicable internal revenue service form that reasonably necessary order amgen determine whether withhold such payment withhold such payment reduced rate under code other including applicable bilateral income treaty nbsp nbsp amgen shall give reasonable support that withholding value added minimized avoided extent permitted under applicable treaty nbsp nbsp each party shall provide other with reasonable assistance enable recovery permitted applicable withholding value added similar obligation resulting from payment made under this agreement such recovery benefit party bearing such withholding value added nbsp nbsp amgen shall require sublicensees territory cooperate with arrowhead manner consistent with this section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font resulting from amgen action font style font weight normal nbsp nbsp amgen required make payment arrowhead that subject increased deduction withholding result willful action amgen such assignment sublicense amgen failure part amgen comply with applicable filing record retention requirement font amgen withholding action font style font weight normal then payable amgen respect which such increased deduction withholding required made shall increased extent necessary ensure that arrowhead receives equal which would have received such amgen withholding action occurred nbsp nbsp notwithstanding foregoing assignment sublicense amgen that agreed consented arrowhead advance writing shall constitute amgen withholding action nbsp nbsp extent that arrowhead actually realizes benefit jurisdiction result such withholding paid amgen pursuant this section arrowhead shall cooperate with amgen convey additional benefit possible amgen font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align center margin bottom margin text indent font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal name _dv_m name _toc name _aeioulastrenderedpagebreakaeiou name _ref font style font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal article font font style font family time roman text transform none name _ref font font style font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal intellectual property matter font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _toc font style margin left font invention font style font weight normal font nbsp nbsp font style font weight normal invention whether patentable whether invented solely party employee agent consultant independent contractor including partner joint venturer licensee sublicensee similar arrangement invented party employee agent consultant independent contractor jointly with employee agent consultant independent contractor other party each case course conducting party activity under this agreement including development manufacture commercialization licensed compound licensed product together with intellectual property right therein shall referred herein font invention font style font weight normal nbsp nbsp inventorship shall determined accordance with patent without reference conflict principle font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _ref font style margin left font ownership font style font weight normal name _ref nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font font style font weight normal except otherwise expressly provided this agreement invention solely invented more employee agent consultant subcontractor independent contractor party such invention intellectual property right therein shall solely owned such party invention jointly invented more employee agent consultant subcontractor independent contractor each party such invention font joint invention font style font weight normal each patent claiming such joint invention each font joint patent font style font weight normal other intellectual property right such joint invention such intellectual property right together with such joint patent font joint font style font weight normal shall jointly owned party nbsp nbsp subject term this agreement except otherwise licensed other party under this agreement subject other intellectual property owned party each party shall entitled practice exploit joint invention joint subject license granted under article without duty accounting paying share proceeds seeking consent from other party each party hereby waif right have under jurisdiction require such accounting payment consent provided however that joint patent that amgen inventive contribution would arrowhead platform patent amgen right practice exploit joint patent shall limited with rnai molecule directed toward collaboration target licensed compound licensed product nbsp nbsp each party agrees named party necessary bring maintain lawsuit involving joint invention joint nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal each party shall notify other party promptly after developing invention which other party sole owner nbsp nbsp each party shall assign hereby assigns other party entire right title interest such invention patent other intellectual property right therein needed implement ownership patent accordance with provision section nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _toc font style margin left font font style font weight normal nothing this agreement shall obligate either party transfer ownership interest patent other intellectual property right such party existing effective date font background font style font weight normal name _toc font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _toc name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight bold font size font family time roman font style normal text transform none font variant normal prosecution patent font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font arrowhead patent font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font font style font weight normal subject section between party arrowhead shall have sole right prepare file prosecute maintain arrowhead patent listed platform patent font font style text decoration underline font weight normal exhibit font font style font weight normal font font style text decoration underline font weight normal font font style font weight normal filed after effective date during term except arrowhead product patent defined section each case including patent that claim priority directly indirectly from such patent patent from which such patent claim priority directly indirectly collectively font arrowhead platform patent font style font weight normal arrowhead cost expense nbsp nbsp clarity arrowhead background controlled arrowhead affiliate effective date that becomes subject patent claim included arrowhead platform patent nbsp nbsp calendar quarter basis arrowhead shall update amgen status prosecution maintenance arrowhead platform patent shall provide amgen with copy material filing with communication from patent authority with respect such patent extent applicable licensed compound licensed product nbsp nbsp arrowhead shall respond reasonable request amgen additional information with respect such prosecution maintenance effort nbsp nbsp arrowhead agrees discus consider good faith recommendation amgen toward objective optimizing overall patent protection licensed compound during term licensed product during term nbsp nbsp arrowhead decides cease prosecution maintenance claim arrowhead platform patent that claim development manufacture commercialization licensed compound licensed product territory shall notify amgen writing sufficiently advance that amgen discretion assume responsibility prosecution maintenance such arrowhead platform patent extent claiming development manufacture commercialization licensed compound licensed product territory amgen cost expense nbsp nbsp amgen assumes such responsibility jurisdiction then such claim shall deemed valid claim such jurisdiction nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _aeioulastrenderedpagebreakaeiou font style margin left font font style font weight normal between party prior exercise option arrowhead shall have first right prepare file prosecute maintain arrowhead patent filed during term having claim solely directed composition matter comprising nucleotide sequence modification pattern licensed compound licensed product method using making licensed compound licensed product collectively font arrowhead product patent font style font weight normal territory arrowhead cost expense from after exercise option amgen shall have first right prepare file prosecute maintain arrowhead product patent territory amgen cost expense nbsp nbsp prosecuting party shall reasonably inform consult with other party shall take other party comment into good faith consideration with respect preparation prosecution maintenance such arrowhead product patent nbsp nbsp promptly following exercise option arrowhead shall transfer control arrowhead product patent amgen nbsp nbsp prosecuting party shall provide other party copy correspondence relating filing prosecution maintenance such arrowhead product patent reasonably advance their being filed promptly upon their being received including draft filing reasonably advance their being filed that other party comment provide input with respect such draft filing nbsp nbsp prosecuting party agrees discus consider good faith change font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal reasonably requested font font style font weight normal other font font style font weight normal party font font style font weight normal such font font style font weight normal correspondence font font style font weight normal including draft filing font font style font weight normal font font style font weight normal promptly font font style font weight normal practicable font font style font weight normal upon their being received font font style font weight normal font font style font weight normal toward objective optimizing overall patent protection licensed compound font font style font weight normal licensed product font font style font weight normal font font style font weight normal font font style font weight normal nbsp nbsp font font style font weight normal font font style font weight normal prosecuting party font font style font weight normal decides cease prosecution maintenance font font style font weight normal font font style font weight normal font font style font weight normal arrowhead font font style font weight normal product patent shall notify font font style font weight normal other party font font style font weight normal writing sufficiently advance that font font style font weight normal other party font font style font weight normal font font style font weight normal discretion assume responsibility prosecution maintenance such font font style font weight normal arrowhead font font style font weight normal product patent font font style font weight normal such other party font font style font weight normal cost expense font font style font weight normal nbsp nbsp notwithstanding foregoing font font style font weight normal while arrowhead prosecuting party pursuant clause font font style font weight normal above arrowhead shall file patent application with respect arrowhead product patent without prior written consent amgen unreasonably withheld conditioned delayed font font style font weight normal font font style font weight normal font font style font weight normal nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal following effective date party shall meet discus extent which feasible allocate certain claim arrowhead platform patent arrowhead product patent nbsp nbsp reasonable request amgen arrowhead shall make such filing party reasonably agree allocate claim solely claiming licensed compound licensed product field arrowhead product patent nbsp nbsp party shall equally share cost associated with such action reasonably requested amgen font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref font style margin left font joint patent font style font weight normal nbsp nbsp amgen shall have first right prepare file prosecute maintain joint patent territory amgen cost expense amgen shall reasonably inform consult with arrowhead shall take such other arrowhead comment into good faith consideration with respect preparation prosecution maintenance such joint patent nbsp nbsp amgen shall provide arrowhead copy correspondence relating filing prosecution maintenance such joint patent reasonably advance their being filed promptly upon their being received including draft filing reasonably advance their being filed that arrowhead comment provide input with respect such draft filing nbsp nbsp amgen agrees discus consider good faith change reasonably requested arrowhead such correspondence including draft filing promptly upon their being received toward objective optimizing overall patent protection licensed compound licensed product nbsp nbsp amgen decides cease prosecution maintenance joint patent shall notify arrowhead writing sufficiently advance that arrowhead discretion assume responsibility prosecution maintenance such joint patent arrowhead cost expense nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font cooperation font style font weight normal nbsp nbsp each party shall provide other party reasonable assistance cooperation other party request expense patent prosecution effort provided above this section including providing necessary power attorney executing other required document instrument such prosecution nbsp nbsp each party shall execute deliver other assignment with respect patent including joint invention applicable mutually agreeable form will take whatever action reasonably necessary including appointment other party attorney fact solely make such assignment effect such assignment accordance with ownership provision provided above section nbsp nbsp prosecuting party under this section agrees conduct such prosecution toward objective optimizing overall patent protection licensed compound licensed product font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight bold font size font family time roman font style normal text transform none font variant normal enforcement font font style font weight bold font size font family time roman font style normal text transform none font variant normal arrowhead font font style font weight bold font size font family time roman font style normal text transform none font variant normal patent font font style font weight bold font size font family time roman font style normal text transform none font variant normal joint patent font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font notification font style font weight normal nbsp nbsp either party becomes aware existing threatened infringement arrowhead patent joint patent with respect third party product involving rnai molecule field territory which infringing activity involves using making importing offering sale selling rnai molecule directed collaboration target licensed compound licensed product each case field territory such arrowhead patent joint patent challenged action proceeding extent directly relating rnai molecule directed collaboration target licensed compound licensed product each case field nbsp nbsp territory other than opposition cancellation interference reissue proceeding reexamination which addressed section font product infringement font style font weight normal shall promptly notify other party writing that effect party will consult with each other regarding action taken with respect such product infringement nbsp nbsp each party shall share with other party information available regarding such alleged product infringement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font enforcement font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal arrowhead shall have first right obligation bring appropriate suit other action against person entity engaged product infringement arrowhead platform patent nbsp nbsp arrowhead shall keep amgen regularly informed status progress such enforcement effort shall reasonably consider amgen comment such effort shall seek consent amgen important aspect such enforcement including determination litigation strategy filing material paper competent court which consent shall unreasonably withheld delayed nbsp nbsp addition arrowhead shall provide amgen with draft material paper filed with court shall good faith incorporate reasonable comment thereto amgen before filing such paper nbsp nbsp amgen shall provide arrowhead reasonable assistance such enforcement pursuant this subsection arrowhead request expense including joining such action party plaintiff required applicable pursue such action font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal arrowhead elect commence suit enforce applicable arrowhead platform patent settle otherwise secure abatement such product infringement then amgen shall have right obligation commence suit take action enforce such arrowhead platform patent against such product infringement field territory cost expense nbsp nbsp such event promptly after arrowhead notice amgen that elect enforce such arrowhead platform patent party shall meet discus good faith strategy enforcing such arrowhead platform patent nbsp nbsp amgen acknowledges agrees that arrowhead platform patent licensed third party have right with respect enforcement such patent that amgen right conduct enforcement activity subject such right nbsp nbsp event arrowhead shall have right consult with such third party licensee prior making decision with respect enforcement activity under this section nbsp nbsp addition amgen shall provide arrowhead with draft material paper filed with court shall incorporate reasonable comment thereto arrowhead before filing such paper nbsp nbsp arrowhead shall entitled separate representation such matter counsel choice expense font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight normal amgen font font style font weight normal shall have first right obligation bring control appropriate suit other action against person entity engaged product infringement font font style font weight normal arrowhead font font style font weight normal product patent joint patent name entirely under direction control subject following nbsp nbsp font font style font weight normal amgen font font style font weight normal shall keep font font style font weight normal arrowhead font font style font weight normal regularly informed status progress such enforcement effort nbsp nbsp font font style font weight normal amgen font font style font weight normal shall consult with font font style font weight normal arrowhead font font style font weight normal take font font style font weight normal arrowhead font font style font weight normal comment into good faith consideration with respect infringement claim construction defense validity enforceability claim font font style font weight normal arrowhead font font style font weight normal product patent joint patent nbsp nbsp addition font font style font weight normal amgen font font style font weight normal shall provide font font style font weight normal arrowhead font font style font weight normal with draft material paper filed with court shall incorporate reasonable comment thereto font font style font weight normal arrowhead font font style font weight normal before filing such paper nbsp nbsp font font style font weight normal arrowhead font font style font weight normal shall provide font font style font weight normal amgen font font style font weight normal reasonable assistance such enforcement pursuant this section font font style font weight normal amgen font font style font weight normal request expense including joining such action party plaintiff requested font font style font weight normal amgen font font style font weight normal required applicable pursue such action nbsp nbsp font font style font weight normal arrowhead font font style font weight normal shall entitled separate representation such matter counsel choice expense font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal amgen elect settle bring action proceeding described section then will notify arrowhead thereof arrowhead bring such suit other action against person entity engaged product infringement arrowhead product patent joint patent name entirely under direction control subject following nbsp nbsp arrowhead shall consult with amgen take amgen comment into good faith consideration with respect infringement claim construction defense validity enforceability claim arrowhead product patent joint patent nbsp nbsp amgen shall provide arrowhead reasonable assistance such enforcement pursuant this section arrowhead request expense including joining such action party plaintiff requested arrowhead required applicable pursue such action nbsp nbsp amgen shall have right participate represented such suit counsel expense with respect product infringement nbsp nbsp settlement such action proceeding which restricts scope adversely affect enforceability arrowhead product patent joint patent imposes amgen restriction obligation other liability shall entered into arrowhead without prior written consent amgen which consent shall unreasonably withheld conditioned delayed nbsp nbsp arrowhead shall knowingly take action during such litigation arrowhead product patent joint patent that would materially adversely affect them without amgen prior written consent which shall unreasonably withheld delayed conditioned nbsp nbsp notwithstanding foregoing arrowhead will have right enforce settle such action proceeding amgen good faith belief that enforcement such arrowhead product patent joint patent such circumstance could unreasonably jeopardize right licensed amgen under such patent font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name ole_link name ole_link font style margin left font font style font weight normal name ole_link name ole_link notwithstanding section third party submits application appropriate regulatory authority approval sell drug product support application with safety efficacy other data that either party generated developing licensed compound licensed product then following will apply font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style margin left font font style font weight normal party receives from third party notice alleging that third party manufacture sale drug product infringe arrowhead patent that such patent invalid unenforceable such certification under font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal under other anywhere world that effect permit third party support application approval with safety efficacy other data generate font font style font weight normal font font style font weight normal developing font font style font weight normal licensed compound font font style font weight normal licensed product then party receiving notice will provide other party facsimile overnight courier soon practicable least within five after receiving notice font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal arrowhead will have first right obligation institute control where arrowhead plaintiff defend control where arrowhead defendant action before government private tribunal against third party concerning infringement validity enforceability arrowhead platform patent settle claim connection with such patent nbsp nbsp amgen will have first right obligation institute control where amgen plaintiff defend control where amgen defendant action before government private tribunal against third party concerning infringement validity enforceability arrowhead product patent settle claim connection with such patent nbsp nbsp applicable party decides institute defend applicable such action such party will give notice other party decision within twenty deadline initiating action such party defending action within twenty deadline required maintain action upon receipt which other party institute defend applicable control such action nbsp nbsp each party will cooperate fully with other party such action will provide reasonable assistance including making available such other party document possessed such party that reasonably required such other party making available personnel interview testimony action undertaken accordance with this section nbsp nbsp controlling party request other party agrees join such action case arrowhead reasonable effort cause third party licensor under license agreement between arrowhead such third party pursuant which arrowhead obtained right arrowhead licensed technology including agreement forth font font style text decoration underline font weight normal exhibit font font style font weight normal join such action purpose establishing standing nbsp nbsp each party will have right approve settlement under section that would adversely affect arrowhead patent result liability restriction obligation admission behalf such party such approval unreasonably withheld conditioned delayed nbsp nbsp recovery settlement otherwise realized result such litigation will allocated accordance with section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font settlement font style font weight normal nbsp nbsp neither party shall settle claim suit action that brought under section without prior written consent other party unreasonably withheld delayed conditioned nbsp nbsp nothing this article shall require such other party consent settlement that reasonably anticipated such other party have material adverse impact upon arrowhead patent joint patent font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style margin left font expense recovery font style font weight normal font nbsp nbsp font style font weight normal enforcing party bringing claim suit action under section shall solely responsible expense incurred such party result such claim suit action nbsp nbsp such party recovers monetary damage such claim suit action such recovery shall first allocated reimbursement expense incurred party such litigation including this purpose reasonable allocation expense internal counsel nbsp nbsp such recovery insufficient cover such cost expense both party shall shared proportion total such cost expense incurred each font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal party nbsp nbsp after such reimbursement fund remain from such damage other recovered font font style font weight normal amgen font font style font weight normal brought such suit such remaining fund shall font font style font weight normal font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font infringement other than product infringement font style font weight normal nbsp nbsp infringement arrowhead patent joint patent other than product infringement between party arrowhead shall have sole exclusive right bring appropriate suit other action against person entity engaged such other infringement arrowhead patent sole discretion shall bear related expense retain related recovery each party shall have right bring appropriate suit other action against person entity engaged such other infringement joint patent sole discretion shall bear related expense retain related recovery other party shall provide reasonable assistance such enforcement action including joining such action party plaintiff required applicable pursue such action request expense party bringing suit action nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _toc font style margin left font patent licensed from third party font style font weight normal nbsp nbsp each party right under this article with respect prosecution maintenance enforcement arrowhead patent that licensed arrowhead from third party shall subject right such third party prosecute maintain enforce such patent font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font infringement third party right territory font style font weight normal nbsp nbsp licensed compound licensed product used sold amgen affiliate sublicensees becomes subject third party claim assertion infringement patent granted jurisdiction within territory amgen shall promptly notify arrowhead party shall agree enter into common interest agreement wherein party agree their shared mutual interest outcome such potential dispute thereafter party shall promptly meet consider claim assertion appropriate course action nbsp nbsp amgen shall solely responsible defense such infringement claim provided that amgen shall provide arrowhead ability join such action arrowhead request expense pursue such action which patent asserted third party under this section claim composition matter sale offer sale importation field licensed compound licensed product manufacture such licensed compound licensed product using process employed arrowhead effective date such patent font subject patent font style font weight normal nbsp nbsp extent directly related subject patent amgen shall keep arrowhead regularly informed status progress action extent involving subject patent shall reasonably consider arrowhead comment such action with respect such subject patent including determination litigation strategy filing material paper competent court nbsp nbsp addition amgen shall provide arrowhead with draft material paper filed with court extent directly related subject patent shall good faith incorporate reasonable comment thereto arrowhead before filing such paper font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style margin left font party patent right font style font weight normal nbsp nbsp arrowhead patent joint patent becomes subject proceeding commenced third party within territory connection with opposition reexamination request action declaratory judgment nullity action interference inter partes review other attack upon validity title enforceability thereof except insofar such action counterclaim defense accompanies defense action infringement against third party under section which case provision section font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal shall govern then font font style font weight normal arrowhead font font style font weight normal shall control such defense with respect font font style font weight normal arrowhead font font style font weight normal platform font font style font weight normal patent font font style font weight normal amgen font font style font weight normal shall control such defense with respect font font style font weight normal arrowhead product patent font font style font weight normal joint patent nbsp nbsp defending party shall responsible cost expense incurred such party under this section nbsp nbsp defending party shall provide other party copy paper relating such opposition reexamination request action declaratory judgment nullity action interference other attack upon font font style font weight normal arrowhead font font style font weight normal font font style font weight normal platform patent arrowhead product patent font font style font weight normal joint patent applicable reasonably advance their being filed promptly upon their being received including draft filing reasonably advance their being filed that other party comment provide input with respect such draft filing nbsp nbsp defending party agrees discus font font style font weight normal consider font font style font weight normal good faith change reasonably requested other party such paper including draft filing promptly upon their being received font font style font weight normal font font style font weight normal toward objective optimizing overall patent protection licensed font font style font weight normal compound font font style font weight normal licensed product font font style font weight normal nbsp nbsp defending party shall permit other party participate proceeding font font style font weight normal font font style font weight normal font font style font weight normal arrowhead font font style font weight normal platform patent arrowhead product patent font font style font weight normal font font style font weight normal joint patent applicable extent permissible under applicable represented counsel such proceeding such other party expense nbsp nbsp defending party decides that wish defend against such action then other party shall have backup right assume defense such third party action expense nbsp nbsp award amount received defending such third party action shall allocated between party provided section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _toc name _toc name _toc name _toc font style margin left font name _toc name _toc patent term extension nbsp nbsp font style font weight normal event amgen desire seek patent term extension including pediatric exclusivity extension available supplemental protection certificate their equivalent country arrowhead product patent joint patent then party shall meet discus such request good faith provided that amgen shall have final decision making authority with respect thereto event amgen desire seek foregoing extension arrowhead platform patent then party shall meet discus such request good faith arrowhead will unreasonably withhold consent such extension provided that shall unreasonable arrowhead withhold consent such extension would materially adversely affect such arrowhead platform patent arrowhead licensee development commercialization compound covered such arrowhead platform patent font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _toc name _toc font style margin left font regulatory data protection font style font weight normal nbsp nbsp extent required permitted amgen will sole discretion decide whether list with applicable regulatory authority during term applicable arrowhead product patent claiming licensed compound licensed product that amgen intends begun commercialize that become subject regulatory approval application submitted nbsp nbsp event amgen desire include such listing arrowhead platform patent then party shall meet discus such request good faith arrowhead will unreasonably withhold consent such listing provided that shall unreasonable arrowhead withhold consent such extension would materially adversely affect such arrowhead platform patent nbsp nbsp such listing include called orange book listing required under hatch waxman listing patent provided patent dispute resolution procedure biologics price competition innovation under similar provision territory during term nbsp nbsp prior such decision listing party will meet evaluate identify applicable patent listed amgen shall reasonably incorporate address suggestion provided arrowhead listing listing applicable patent font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align center margin bottom margin text indent font weight bold text transform uppercase font size font family time roman font style normal font variant normal name _dv_m name _toc name _aeioulastrenderedpagebreakaeiou name _ref font style font weight bold text transform uppercase font size font family time roman font style normal font variant normal article font font style font weight normal text transform none name _ref font font style text transform none representation warranty covenant disclaimer font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _dv_c name _toc name _toc name _dv_c font style margin left font mutual representation warranty font style font weight normal name _dv_c nbsp nbsp each party hereby represents warrant other party follows font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font font style font weight normal name _dv_c effective date corporation duly organized validly existing good standing under jurisdiction which incorporated font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font font style font weight normal effective date corporate power authority legal right enter into this agreement perform obligation hereunder taken necessary corporate action part required authorize execution delivery this agreement performance obligation hereunder name _dv_c this agreement been duly executed delivered behalf such party constitutes legal valid binding obligation such party that enforceable against accordance with term font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _toc name _dv_c name _dv_c font style margin left font additional representation warranty arrowhead font style font weight normal nbsp nbsp arrowhead represents warrant amgen name _dv_c effective date follows font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font font style font weight normal arrowhead right under arrowhead licensed technology grant license amgen purported granted pursuant this agreement sufficient legal beneficial title arrowhead licensed technology grant license amgen purported granted pursuant this agreement granted right license third party under arrowhead licensed technology that would conflict interfere with right license granted amgen name _dv_c hereunder font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font font style font weight normal arrowhead owns right title interest arrowhead patent including those forth font font style text decoration underline font weight normal exhibit font font style font weight normal except arrowhead patent forth font font style text decoration underline font weight normal exhibit font font style font weight normal which patent right arrowhead licensed from third party pursuant corresponding agreement forth font font style text decoration underline font weight normal exhibit font font style font weight normal such licensed right sufficient grant right purported granted amgen under this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c font style margin left font font style font weight normal lien encumbrance security interest including connection with indebtedness exists arrowhead name _dv_c patent favor creditor font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font font style font weight normal existing agreement between arrowhead third party under which arrowhead receives license under intellectual property right relating arrowhead licensed technology listed font font style text decoration underline font weight normal exhibit font font style font weight normal such agreement were made available amgen arrowhead were true accurate complete font font style font style italic font weight normal font font style font weight normal copy such agreement have been modified supplemented amended since date they were made available amgen each such agreement full force effect arrowhead name _dv_c material breach such agreement knowledge other party such agreement material breach thereof each respect manner that would give such other party right terminate such agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _aeioulastrenderedpagebreakaeiou name _dv_c font style margin left font font style font weight normal written communication have been received arrowhead from third party that allege there pending threatened litigation effective date that alleges either that arrowhead patent existence effective date font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal patent application included font font style font weight normal arrowhead font font style font weight normal patent existence effective date issued would invalid unenforceable font font style font weight normal arrowhead font font style font weight normal licensed font font style font weight normal technology manufacture sale offer sale importation font font style font weight normal licensed compound font font style font weight normal licensed product product made using arrowhead font font style font weight normal licensed font font style font weight normal technology infringes misappropriates would infringe misappropriate right third party font font style font weight normal knowledge font font style font weight normal arrowhead font font style font weight normal third party infringing font font style font weight normal arrowhead font font style font weight normal patent existence effective date misappropriated font font style font weight normal arrowhead font font style font weight normal know font font style font weight normal arrowhead font font style font weight normal licensed technology challenged ownership scope duration validity enforceability priority right font font style font weight normal arrowhead font font style font weight normal patent existence effective date including example through institution written threat institution interference reexamination protest opposition font font style font weight normal derivation font font style font weight normal nullity similar invalidity proceeding before patent trademark office analogous foreign entity font font style font weight normal arrowhead font font style font weight normal name _dv_c know existence effective date font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font font style font weight normal each issued patent currently pending patent application patent application from which such patent issued each case within arrowhead name _dv_c patent existence effective date been prosecuted compliance with applicable rule policy procedure patent trademark office material respect subsisting font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font font style font weight normal arrowhead disclosed amgen third party issued patent identified relevant counsel arrowhead freedom operate patentability search opinion relating arrowhead name _dv_c licensed technology existence effective date territory font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font font style font weight normal arrowhead affiliate employee officer involved development licensed technology have been obligated assign arrowhead such affiliate case invention claimed patent such arrowhead licensed technology maintain confidential confidential information arrowhead name _dv_c such affiliate case font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font font style font weight normal inventor invention included within arrowhead patent owned arrowhead have assigned their entire right title interest such invention corresponding patent arrowhead name _dv_c have been listed such patent inventor font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c font style margin left font font style font weight normal neither execution delivery this agreement performance hereof arrowhead requires arrowhead obtain permit authorization consent from governmental authority from other person firm corporation such execution delivery performance will result breach give rise right termination rescission renegotiation acceleration under trigger other right under agreement contract which arrowhead party which subject that relates arrowhead licensed technology font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style margin left font font style font weight normal there pending action claim investigation suit proceeding against arrowhead affiliate equity before governmental authority neither arrowhead affiliate received written notice regarding pending threatened action claim investigation suit proceeding against arrowhead font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal such affiliate equity before governmental authority either case with respect arrowhead font font style font weight normal licensed font font style font weight normal technology font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal arrowhead licensed technology been created developed using government funding that grant right step seize restrict otherwise compromise ability arrowhead such technology grant amgen right purported granted hereunder font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _toc name _dv_c font style margin left font mutual covenant font style font weight normal name _dv_c font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font debarment font style font weight normal nbsp nbsp course development licensed compound licensed product each party shall knowingly name _dv_c employee consultant ever been debarred subject debarment convicted crime which entity person could debarred including under subject similar sanction other governmental authority nbsp nbsp each party shall notify other party promptly upon becoming aware that employee consultant been debarred subject debarment proceeding regulatory authority font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font compliance font style font weight normal nbsp nbsp each party affiliate shall comply material respect with applicable development manufacture commercialization licensed compound licensed product name _dv_c performed under this agreement including statute regulation written directive regulatory authority having jurisdiction territory prescription drug marketing federal health care program anti kickback statute regulation written directive medicare medicaid other health care program defined foreign corrupt practice each amended from time time font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font additional covenant font style font weight normal name _dv_c font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font font style font weight normal arrowhead represents warrant covenant with amgen that arrowhead employee officer involved research development arrowhead licensed technology licensed compound licensed product shall obligated assign arrowhead invention relating such arrowhead licensed technology licensed compound licensed product maintain confidential confidential information arrowhead name _dv_c font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font font style font weight normal amgen represents warrant covenant with arrowhead that amgen employee officer involved development licensed compound licensed product shall obligated assign amgen invention relating such licensed compound licensed product maintain confidential confidential information amgen name _dv_c font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _dv_c font style margin left font font style font weight normal arrowhead represents warrant covenant with amgen that arrowhead shall sell assign otherwise transfer person other than affiliate arrowhead arrowhead patent agree foregoing manner that would inconsistent with right license granted amgen name _dv_c under this agreement except extent permitted compliance with section font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _aeioulastrenderedpagebreakaeiou name _dv_c font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight normal arrowhead font font style font weight normal represents warrant covenant with font font style font weight normal amgen font font style font weight normal that font font style font weight normal arrowhead font font style font weight normal shall grant third party right license under font font style font weight normal arrowhead font font style font weight normal licensed technology that within scope license granted font font style font weight normal amgen font font style font weight normal under section font font style font weight normal name _dv_c would breach article font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _ref name _dv_c name _toc name _dv_c font style margin left font disclaimer font style font weight normal nbsp nbsp amgen understands that licensed compound licensed product will subject research development that arrowhead assure safety usefulness licensed compound licensed product nbsp nbsp addition arrowhead make warranty except forth this article concerning arrowhead name _dv_c name _toc licensed technology font font style font variant small font weight normal nbsp nbsp except font font style font weight normal name _dv_c expressly stated this agreement representation warranty whatsoever whether express implied including warranty merchantability fitness particular purpose infringement misappropriation third party intellectual property right made given behalf party representation warranty whether arising operation otherwise hereby expressly excluded nbsp nbsp without limiting generality foregoing neither party represents warrant success study test conducted such party pursuant this agreement safety usefulness purpose technology right material provides hereunder that either party will successful obtaining patent right that patent will issue based pending application each party specifically disclaims guarantee that licensed compound licensed product will successful whole part font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_c name _toc font style margin left font knowledge standard font style font weight normal nbsp nbsp font knowledge font style font weight normal mean applied party this article actual knowledge effective date party executive officer personnel with primary responsibility applicable subject matter exercising reasonably diligent inquiry font style text align center margin bottom margin text indent font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal name _ref article font style font family time roman font weight normal text transform none name _ref font indemnification style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _toc name _aeioulastrenderedpagebreakaeiou font style margin left font indemnification arrowhead nbsp nbsp font style font weight normal arrowhead shall defend indemnify hold amgen affiliate their respective officer director employee agent font amgen indemnitees font style font weight normal harmless from against third party claim suit proceeding damage expense including court cost reasonable attorney expense recovery collectively font claim font style font weight normal extent that such claim arise based result from breach arrowhead obligation under this agreement including arrowhead representation warranty covenant forth herein performance behalf arrowhead affiliate licensee arrowhead obligation under this agreement development manufacture commercialization arrowhead affiliate licensee other than amgen affiliate sublicensees product containing rnai molecule solely extent such claim based arrowhead licensed technology excluding case claim covered scope arrowhead affiliate licensee other than amgen affiliate sublicensees connection with such development manufacture commercialization such party such product willful misconduct negligent arrowhead affiliate performing under this agreement nbsp nbsp foregoing indemnity obligation shall apply extent that amgen indemnitees fail comply with indemnification procedure forth section arrowhead font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal defense relevant claim font font style font weight normal actually font font style font weight normal prejudiced such failure claim arises from based result from activity forth section which font font style font weight normal amgen font font style font weight normal obligated indemnify font font style font weight normal arrowhead font font style font weight normal indemnitees under section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font indemnification amgen nbsp nbsp font style font weight normal amgen shall defend indemnify hold arrowhead affiliate their respective officer director employee agent font arrowhead indemnitees font style font weight normal harmless from against claim extent that such claim arise based result from development manufacture commercialization licensed compound licensed product behalf amgen affiliate sublicensees including claim based upon product liability patent infringement breach amgen obligation under this agreement including amgen representation warranty covenant forth herein willful misconduct negligent amgen affiliate performing under this agreement infringement third party patent misappropriation third party information extent that such infringement misappropriation attributable directly collaboration target including thereof result arrowhead affiliate performing activity accordance with amgen direction pursuant research program being understood that foregoing clause shall only apply extent amgen dictate particular perform activity activity performed customary manner without knowledge infringement misappropriation arrowhead affiliate nbsp nbsp foregoing indemnity obligation shall apply extent that arrowhead indemnitees fail comply with indemnification procedure forth section amgen defense relevant claim actually prejudiced such failure claim arises from based result from activity forth section which arrowhead obligated indemnify amgen indemnitees under section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _aeioulastrenderedpagebreakaeiou font style margin left font indemnification procedure nbsp nbsp font style font weight normal party claiming indemnity under this article font indemnified party font style font weight normal shall give written notice party from whom indemnity being sought font indemnifying party font style font weight normal promptly after learning such claim nbsp nbsp indemnified party shall provide indemnifying party with reasonable assistance indemnifying party expense connection with defense claim which indemnity being sought indemnifying party failed assume defense such claim indemnified party assumed conducting defense claim indemnifying party shall provide indemnified party with reasonable assistance indemnifying party expense connection with defense claim which indemnity being sought nbsp nbsp indemnified party participate monitor such defense with counsel choosing sole expense provided however indemnifying party shall have right assume conduct defense claim with counsel choice nbsp nbsp indemnifying party shall settle claim without prior written consent indemnified party unreasonably withheld conditioned delayed nbsp nbsp clarity indemnified party freely withhold consent settlement claim with respect claim such settlement include complete release from liability indemnified party such settlement would involve undertaking obligation including payment money indemnified party would bind impair indemnified party includes admission wrongdoing that intellectual property proprietary right indemnified party this agreement invalid narrowed scope unenforceable nbsp nbsp long indemnifying party actively defending claim good faith indemnified party shall settle compromise such claim without prior written consent font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal indemnifying party nbsp nbsp indemnifying party assume conduct defense claim provided above indemnified party defend against consent entry judgment enter into settlement with respect such claim manner indemnified party deem reasonably appropriate indemnified party need consult with obtain consent from indemnifying party connection therewith indemnifying party shall remain responsible indemnify indemnified party provided this article font font style font weight normal nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font limitation liability nbsp nbsp font style font weight normal neither party shall liable other special consequential incidental punitive indirect damage arising from relating breach this agreement regardless notice possibility such damage nbsp nbsp notwithstanding foregoing nothing this section intended shall limit restrict indemnification right obligation party under section with respect third party claim damage available party breach confidentiality obligation article obligation section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font insurance nbsp nbsp font style font weight normal each party shall procure maintain insurance self insure sufficiently provide materially same level type protection adequate cover obligation hereunder during term consistent with normal business practice company similarly situated nbsp nbsp understood that such insurance shall construed create limit either party liability with respect indemnification obligation under this article nbsp nbsp each party shall provide other party with written evidence such insurance upon request nbsp nbsp font style text align center margin bottom margin text indent font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal name _dv_m name _toc name _ref article font style font family time roman font weight normal text transform none name _ref font confidentiality style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _toc name _dv_m font style margin left font confidentiality nbsp nbsp font style font weight normal each party agrees that during term period year thereafter shall keep confidential shall publish otherwise disclose shall purpose other than provided this agreement which includes exercise right performance obligation hereunder confidential information furnished other party pursuant this agreement except extent expressly authorized this agreement otherwise agreed writing party nbsp nbsp name _dv_m each party will least same standard care protect proprietary confidential information than reasonable care ensure that employee agent consultant contractor other representative disclose make unauthorized confidential information other party nbsp nbsp each party will promptly notify other upon discovery unauthorized disclosure confidential information other party nbsp nbsp foregoing confidentiality obligation shall apply portion other party confidential information that font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal already known receiving party affiliate other than previous disclosure disclosing party affiliate time disclosure other party font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style font weight bold font size font family time roman font style normal text transform none font variant normal font font style margin left font font style font weight normal generally available public otherwise part public domain time disclosure receiving party font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal becomes generally available public otherwise part public domain after disclosure other than through omission receiving party breach this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal disclosed receiving party affiliate confidential basis third party known receiving party after inquiry subject obligation confidentiality other party font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal independently discovered developed employee subcontractor consultant agent receiving party affiliate without other party confidential information evidenced contemporaneous writing font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font authorized disclosure font style font weight normal nbsp nbsp notwithstanding obligation forth section party disclose other party confidential information term this agreement extent font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font font style font weight normal such disclosure reasonably necessary comply with requirement regulatory authority with respect obtaining maintaining regulatory approval licensed product prosecuting defending litigation contemplated this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal such disclosure reasonably necessary employee agent consultant contractor licensee sublicensees need know basis sole purpose performing obligation exercising right under this agreement provided that each case disclosees bound written obligation confidentiality consistent with those contained this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal such disclosure reasonably necessary bona fide potential actual investor acquirer merger partner licensee sublicensee other financial commercial partner sole purpose evaluating actual potential investment acquisition other business relationship provided that connection with such disclosure such party shall inform each disclosee confidential nature such confidential information each case disclosees bound written obligation confidentiality consistent with those contained this agreement provided further that financial term shall disclosed such potential investor acquirer partner competing product licensed compound licensed product font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font font style font weight normal such disclosure reasonably necessary comply with applicable including regulation promulgated applicable security exchange court order administrative subpoena order font style text align justify margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou notwithstanding foregoing event party required make disclosure other party confidential information pursuant section such party shall promptly notify other party such required disclosure shall reasonable effort obtain assist other party obtaining protective order preventing limiting required disclosure nbsp nbsp style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal font style font size font family time roman font weight normal font style normal text transform none font variant normal information disclosed pursuant section font font style font size font family time roman font weight normal font style normal text transform none font variant normal font font style font size font family time roman font weight normal font style normal text transform none font variant normal through section font font style font size font family time roman font weight normal font style normal text transform none font variant normal font font style font size font family time roman font weight normal font style normal text transform none font variant normal shall still deemed confidential information subject restriction forth this agreement including foregoing provision font font style font size font family time roman font weight normal font style normal text transform none font variant normal article font font style font size font family time roman font weight normal font style normal text transform none font variant normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font technical publication font style font weight normal nbsp nbsp during term neither party publish peer reviewed manuscript give other form public disclosure such abstract presentation result study carried under this agreement without opportunity prior review other party subject this section below except extent required applicable provided however that amgen will have sole right without arrowhead consent publish make scientific presentation with respect licensed compound licensed product make other public disclosure regarding such licensed compound licensed product arrowhead will without amgen prior written consent except required applicable nbsp nbsp publication shall include other party confidential information without prior written consent such other party nbsp nbsp party seeking publication shall provide other party opportunity review comment proposed publication where copy such publication presentation available such time draft outline such publication description such presentation that relates rnai molecule directed collaboration target licensed compound licensed product least prior intended submission publication nbsp nbsp other party shall provide party seeking publication with comment writing promptly practicable after receipt such proposed publication nbsp nbsp party seeking publication shall consider good faith comment thereto provided other party shall comply with other party request remove such other party confidential information from proposed publication nbsp nbsp addition party seeking publication shall delay submission period event that other party demonstrate reasonable need such delay including preparation filing patent application case that party compelling business justification longer period reasonably selected that party nbsp nbsp each party agrees acknowledge contribution other party employee publication scientifically appropriate font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font publicity term this agreement style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal party agree that term this agreement confidential information both party subject special authorized disclosure provision forth this section font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font font style font weight normal public announcement execution this agreement shall made substantially form press release attached hereto font font style text decoration underline font weight normal exhibit font font style font weight normal promptly after effective date font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style margin left font font style font weight normal after release such press release either party desire make public announcement concerning term this agreement such party shall give reasonable prior advance notice proposed text such announcement other party prior review approval except otherwise provided herein nbsp nbsp party commenting such proposed press release shall provide comment within after receiving press release review nbsp nbsp notwithstanding foregoing party shall have right make public announcement press release announcing achievement each regulatory approval development regulatory milestone event forth section excluding clarity initiation phase font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal clinical trial milestone font font style font weight normal achieved either with consent other party unreasonably withheld where required applicable regulation promulgated applicable security exchange permitted under section nbsp nbsp except provided this subsection permitted under section press release shall include other party confidential information without prior written consent such other party nbsp nbsp relation other party review such announcement such other party make specific reasonable comment such proposed press release within prescribed time commentary nbsp nbsp neither party shall required seek permission other party repeat information regarding term this agreement that already been publicly disclosed such party other party accordance with this section provided such information remains accurate such time font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal party acknowledge that either both party obligated file copy this agreement summary term hereof with security exchange commission other governmental authority reasonably required comply with applicable rule nationally recognized security exchange nbsp nbsp each party shall entitled make such filing provided that request confidential treatment commercial term sensitive technical term other term this agreement that party reasonably deems sensitive competitive extent such confidential treatment reasonably available such party provided that foregoing obligation request confidential treatment shall apply with respect disclosure this agreement either party internal revenue service similar governmental authority outside nbsp nbsp event such filing each party will provide other party with copy this agreement related filing marked show provision which such party intends seek confidential treatment shall reasonably consider incorporate other party comment thereon extent consistent with legal requirement rule nationally recognized security exchange with respect filing party governing disclosure material agreement material information publicly filed font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font equitable relief font style font weight normal nbsp nbsp each party acknowledges that breach this article cause irreparable harm other party which reasonably adequately compensated damage action nbsp nbsp reason thereof each party agrees that other party shall entitled addition other remedy have under this agreement otherwise seek preliminary permanent injunctive other equitable relief prevent curtail actual threatened breach obligation relating confidential information forth this article other party font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font attorney client privilege font style font weight normal nbsp nbsp neither party waiving will deemed have waived diminished attorney work product protection attorney client privilege similar protection privilege recognized under applicable jurisdiction result disclosing information pursuant this agreement confidential information including confidential information related pending threatened litigation receiving party regardless whether disclosing party asserted entitled assert such privilege protection nbsp nbsp party become joint defendant proceeding which information covered such protection privilege relates determine that they share common legal interest disclosure between them that subject such privilege protection such event enter into joint defense agreement setting forth among other thing foregoing principle obligated font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align center margin bottom margin text indent font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal name _dv_m name _toc name _aeioulastrenderedpagebreakaeiou font style font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal article font font style font family time roman font weight normal text transform none font font style font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal term termination font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _toc font style margin left font term font style font weight normal nbsp nbsp this agreement shall become effective effective date unless earlier terminated pursuant this article shall remain effect until expiration option period including extension thereto amgen exercise option until last expiration royalty term licensed product font term font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _toc name _toc font style margin left font termination amgen font style font weight normal nbsp nbsp amgen terminate this agreement entirety time reason reason upon delivery least prior written notice arrowhead first commercial sale occurred with respect licensed product least prior written notice arrowhead first commercial sale occurred with respect licensed product nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref font style margin left font termination breach font style font weight normal nbsp nbsp each party font breaching party font style font weight normal shall have right without prejudice other remedy available equity terminate this agreement entirety upon written notice other party other party materially breach obligation under this agreement after receiving written notice identifying such material breach reasonable detail fails cure such material breach such material breach susceptible cure within cure period fails deliver breaching party written plan that reasonably calculated resolve such material breach within ninety from date such notice within thirty from date such notice event such material breach solely based breaching party failure undisputed amount hereunder font cure period font style font weight normal nbsp nbsp party reasonably good faith disagree whether there been material breach party that dispute that there been material breach contest allegation accordance with article nbsp nbsp understood acknowledged that during pendency such dispute cure period shall extended period time such pendency term condition this agreement shall remain effect party shall continue perform their respective obligation under this agreement provided that dispute over payment such tolling cure period will only apply with respect payment disputed amount with respect undisputed amount nbsp nbsp nothing this section shall limit party ability seek remedy available under this agreement equity font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _aeioulastrenderedpagebreakaeiou font style margin left font termination patent challenge font style font weight normal nbsp nbsp arrowhead terminate this agreement entirety immediately upon written notice amgen amgen affiliate directly indirectly challenge validity enforceability scope arrowhead patent anywhere world sublicensee directly indirectly challenge validity enforceability scope arrowhead patent anywhere world amgen cause such sublicensee withdraw such action amgen initiate termination sublicense agreement with such sublicensee each case within amgen receiving from arrowhead written notice such action being taken such sublicensee nbsp nbsp notwithstanding foregoing arrowhead shall have such right terminate this agreement case amgen affiliate good faith assertion that invention claimed patent filed behalf arrowhead arrowhead patent invention amgen joint invention invention claimed joint patent filed behalf arrowhead joint patent invention amgen amgen affiliate good faith assertion font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal context whether payment royalty arrowhead that valid claim within arrowhead patent font font style font weight normal licensed from third party font font style font weight normal applies with respect licensed product font font style font weight normal claim made amgen affiliate sublicensees defense lawsuit administrative proceeding brought font font style font weight normal arrowhead font font style font weight normal lawsuit reexamination proceeding opposition brought amgen affiliate sublicensees challenging validity enforceability claim within issued font font style font weight normal arrowhead font font style font weight normal patent that claim font font style font weight normal arrowhead licensed font font style font weight normal technology that licensed amgen under font font style font weight normal font font style font weight normal exploit font font style font weight normal licensed compound font font style font weight normal licensed product font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font consequence termination font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font font style font weight normal upon termination this agreement pursuant section except otherwise forth section name _dv_m license right granted either party under this agreement shall terminate font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font font style font weight normal upon termination this agreement amgen pursuant section addition consequence provided elsewhere this agreement provision section shall apply such termination expiration option term nbsp nbsp upon termination this agreement amgen pursuant accordance with section breach arrowhead provision section following such termination shall apply font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font survival font style font weight normal nbsp nbsp termination expiration this agreement shall affect liability party under this agreement that have accrued prior date termination expiration nbsp nbsp notwithstanding anything contrary following provision shall survive expiration termination this agreement article article article period forth section article except section section each such listed section article extent applicable payment milestone event sale licensed product that occurred prior effective date such termination expiration payable amgen under article applicable font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font limitation remedy font style font weight normal nbsp nbsp notwithstanding anything contrary this agreement termination expiration this agreement shall relieve party liability obligation which accrued hereunder prior effective date such termination expiration prejudice either party right obtain performance obligation nbsp nbsp subject term condition this agreement each party shall free seek without restriction number time seek damage cost remedy that available equity shall entitled offset amount damage cost obtained final appealable judgment judgment from which appeal taken within allowable time period monetary damage cost permitted this agreement against other party against amount otherwise such other party under this agreement font style text align center margin bottom margin text indent font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal name _dv_m name _toc name _ref article font style font family time roman font weight normal text transform none name _ref font initial dispute resolution style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _ref name _toc name _toc name _toc name _aeioulastrenderedpagebreakaeiou name _ref font style margin left font dispute font style font weight normal nbsp nbsp party recognize that controversy claim arising relating connection with provision this agreement certain matter from time font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal time arise that relate either party right obligation hereunder collectively font font style font weight bold font size font family time roman font style normal text transform none font variant normal dispute font font style font weight normal name _ref nbsp nbsp objective party establish procedure facilitate resolution dispute expedient manner mutual cooperation nbsp nbsp font font style font weight normal accordingly with font font style font weight normal respect dispute including alleged breach under this agreement issue relating interpretation application this agreement party unable resolve such dispute within font font style font weight normal font font style font weight normal after such dispute first identified either party writing other party shall refer such dispute executive officer party attempted resolution good faith negotiation font font style font weight normal prior commencing litigation accordance with font font style font weight normal section font font style font weight normal font font style font weight normal font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font preliminary injunction font style font weight normal nbsp nbsp notwithstanding anything this agreement contrary party time seek temporary restraining order preliminary injunction from court competent jurisdiction order prevent immediate irreparable injury loss damage provisional basis font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font patent dispute font style font weight normal nbsp nbsp notwithstanding anything this agreement contrary issue regarding validity enforceability patent country within territory shall determined court other tribunal case competent jurisdiction under applicable patent such country except issue that depends validity scope enforceability joint invention which shall determined accordance with federal font style text align center margin bottom margin text indent font weight bold font family time roman bold text transform uppercase font size font style normal font variant normal name _dv_m name _toc name _ref article font style font family time roman font weight normal text transform none name _ref font miscellaneous style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc name _ref name _toc name _dv_m font style margin left font english language governing jurisdiction font style font weight normal nbsp nbsp this agreement prepared english language which language shall govern interpretation dispute regarding term this agreement nbsp nbsp this agreement dispute arising related this agreement breach hereof shall governed construed under state york name _dv_m without giving effect choice principle that would require application different jurisdiction nbsp nbsp each party hereby irrevocably unconditionally consent submit exclusive jurisdiction federal state court located state york matter arising relating this agreement transaction contemplated hereby agrees commence litigation relating thereto except such court nbsp nbsp each party hereby irrevocably unconditionally waif objection laying venue matter arising this agreement transaction contemplated hereby federal state court located city state york hereby further irrevocably unconditionally waif agrees plead claim such court that such matter brought such court been brought inconvenient forum nbsp nbsp party agree that final judgment such matter shall conclusive enforced other jurisdiction suit judgment other manner provided nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou name _dv_m name _toc font style margin left font entire agreement amendment font style font weight normal nbsp nbsp this agreement including exhibit hereto stock purchase agreement forth complete final exclusive agreement covenant promise agreement warranty representation condition understanding between party with respect subject matter hereof supersedes effective date prior contemporaneous agreement understanding between party with respect subject matter hereof including confidentiality agreement nbsp nbsp subsequent font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal alteration amendment change addition this agreement shall binding upon party unless reduced writing font font style font weight normal name _dv_m name _toc signed authorized officer each party font font style font weight normal font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font force majeure font style font weight normal nbsp nbsp both party shall excused from performance their obligation under this agreement extent that such performance prevented force majeure nonperforming party promptly provides notice prevention other party nbsp nbsp such excuse shall continued long condition constituting force majeure continues nonperforming party take reasonable effort remove condition nbsp nbsp purpose this agreement force majeure shall include condition beyond control party including terrorist labor strike lock epidemic fire earthquake storm font font style font size font family arial font weight normal font font style font weight normal name _dv_m name _toc release radioactive material into environment like catastrophe nbsp nbsp notwithstanding foregoing party shall excused from making payment owed hereunder because force majeure affecting such party nbsp nbsp force majeure persists more than ninety then party will discus good faith modification party obligation under this agreement order mitigate delay caused such force majeure font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref font style margin left font notice font style font weight normal nbsp nbsp notice required permitted given under this agreement shall writing shall specifically refer this agreement shall addressed appropriate party address specified below such other address specified such party writing accordance with this section shall deemed have been given purpose when received hand delivered sent confirmed facsimile reputable courier service five business after mailing mailed first class certified registered airmail postage prepaid return receipt requested font align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size nbsp valign style width white space nowrap style margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal font style font size font family time roman font weight normal font style normal text transform none font variant normal font font style font size font family time roman font weight normal font style normal text transform none font variant normal arrowhead font font style font size font family time roman font weight normal font style normal text transform none font variant normal nbsp nbsp font valign style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size name _dv_m arrowhead pharmaceutical table align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size nbsp valign style width white space nowrap style margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal valign style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size lake suite table align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size nbsp valign style width white space nowrap style margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal valign style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size pasadena attn general counsel table align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size nbsp valign style width white space nowrap style margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal valign style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size facsimile table style margin bottom margin margin left text indent font family time roman font size nbsp align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal valign style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size name _dv_m with copy which shall constitute notice table style margin bottom margin margin left text indent font family time roman font size nbsp align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size nbsp valign style width white space nowrap style margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal valign style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size name _dv_m gibson dunn crutcher mission street suite francisco california attn ryan murr table align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal valign style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size facsimile table style margin bottom margin margin left text indent font family time roman font size nbsp align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size nbsp valign style width white space nowrap style margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal font style font size font family time roman font weight normal font style normal text transform none font variant normal font font style font size font family time roman font weight normal font style normal text transform none font variant normal amgen font font style font size font family time roman font weight normal font style normal text transform none font variant normal nbsp nbsp font valign style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size name _dv_m amgen amgen center drive thousand california attention corporate secretary table style margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal facsimile style margin bottom margin margin left text indent font family time roman font size nbsp style margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal name _dv_m name ole_link name ole_link with copy which shall constitute notice style margin bottom margin margin left text indent font family time roman font size nbsp style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size nbsp valign style width white space nowrap style margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal font style font size font family time roman font weight normal font style normal text transform none font variant normal font valign style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size name _dv_m name _aeioulastrenderedpagebreakaeiou font style font size font family time roman font weight normal font style normal text transform none font variant normal font font style font size font family time roman font weight normal font style normal text transform none font variant normal font font style font size font family time roman font weight normal font style normal text transform none font variant normal amgen font font style font size font family time roman font weight normal font style normal text transform none font variant normal amgen center drive font font style font size font family time roman font weight normal font style normal text transform none font variant normal thousand california font font style font size font family time roman font weight normal font style normal text transform none font variant normal attention business development font table style margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal facsimile style margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc name _dv_m name _dv_m name _toc font style margin left font strict construction heading font style font weight normal nbsp nbsp this agreement been prepared jointly party shall strictly construed against either party nbsp nbsp ambiguity this agreement shall construed against party irrespective which party deemed have authored ambiguous provision nbsp nbsp heading each article section this agreement have been inserted convenience reference only intended limit expand meaning language contained particular article section nbsp nbsp gender shall applicable gender nbsp nbsp word used inclusive sense unless context dictate otherwise because subject conjunction mutually exclusive name _dv_m nbsp nbsp term including mean including without limitation without limiting generality description preceding such term name _dv_m name _toc nbsp nbsp term shall mean will font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _dv_m font style margin left font assignment font style font weight normal name _dv_m nbsp nbsp font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _dv_m font style margin left font font style font weight normal neither party assign transfer this agreement right obligation hereunder without prior written consent other party except that party make such assignment transfer without other party consent affiliate long such entity remains affiliate only entire agreement just certain right obligation third party acquiror affiliate connection with change control such party such third party font acquiror font style font weight normal name _dv_m nbsp nbsp successor assignee right obligation permitted hereunder shall writing other party expressly assume performance such right obligation nbsp nbsp permitted assignment shall binding successor assigning party nbsp nbsp assignment attempted assignment either party violation term this section shall null void legal effect font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _dv_m name _toc name _aeioulastrenderedpagebreakaeiou font style margin left font font style font weight normal event such assignment under section connection with change control arrowhead intellectual property right including information patent owned otherwise controlled acquiror affiliate except arrowhead remaining separate affiliate otherwise successor entity thereto shall excluded from license granted amgen under this agreement arrowhead research arrowhead name _dv_m name _toc licensed technology including each case such intellectual property right including information patent owned otherwise controlled such acquiror date consummation such transaction except invention generated acquiror affiliate performing activity under this agreement nbsp nbsp notwithstanding foregoing case either change control arrowhead acquisition arrowhead substantially business third party together with entity that were affiliate such third party immediately prior such acquisition font acquiree font style font weight normal whether merger consolidation divesture restructure sale stock sale asset otherwise font acquisition font style font weight normal extent that third party acquirer such change control such acquiree applicable owns blocking patent relative licensed compound licensed product arrowhead shall hereby grant amgen exclusive license font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal additional consideration provided however that event that arrowhead would obligated make payment third party connection with grant foregoing license blocking patent then unless amgen agrees assume such payment obligation such license grant will exclude license under applicable blocking patent until expiration last expire such blocking patent country country basis termination this agreement relative such font font style font weight normal licensed compound font font style font weight normal licensed product whichever come first provided that time such transaction contemplated such exclusive license right available such grant have been exclusively licensed third party font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _dv_m name _toc font style margin left font font style font weight normal event such assignment under section connection with change control amgen intellectual property right including information patent owned otherwise controlled acquiror affiliate except amgen remaining separate affiliate otherwise successor entity thereto shall excluded from license granted arrowhead name _dv_m name _toc under this agreement including such intellectual property right including information patent owned otherwise controlled such acquiror date consummation such transaction except invention generated acquiror affiliate performing activity under this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m font style margin left font further action font style font weight normal name _dv_m nbsp nbsp each party agrees execute acknowledge deliver such further instrument such other necessary appropriate order carry purpose intent this agreement font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _ref name _aeioulastrenderedpagebreakaeiou name _dv_m name _toc font style margin left font right bankruptcy font style font weight normal nbsp nbsp right license granted under pursuant this agreement arrowhead shall otherwise deemed purpose section bankruptcy code license right intellectual property defined under section bankruptcy code nbsp nbsp party agree that amgen licensee such right under this agreement shall retain fully exercise right election under bankruptcy code including without limitation amgen right retain license arrowhead licensed technology granted herein nbsp nbsp without limiting generality foregoing party intend agree that sale arrowhead asset under section bankruptcy code shall subject amgen right under section that amgen compelled accept money satisfaction interest arrowhead licensed technology that such sale therefore made purchaser free clear amgen license right without consent amgen nbsp nbsp party further agree that event commencement bankruptcy proceeding against arrowhead under bankruptcy code amgen shall entitled complete duplicate complete access appropriate such intellectual property embodiment such intellectual property same already possession shall promptly delivered them upon such commencement bankruptcy proceeding upon written request therefor unless arrowhead elect continue perform obligation under this agreement delivered under above following rejection this agreement behalf arrowhead upon written request therefor amgen party acknowledge agree that embodiment intellectual property within meaning section include without limitation laboratory notebook rnai molecule inventory research study data regulatory approval nbsp nbsp additionally case under bankruptcy code commenced against arrowhead this agreement rejected provided bankruptcy code amgen elect retain right hereunder provided section font style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin font weight bold font size font family time roman font style normal text transform none font variant normal font style font weight normal bankruptcy code arrowhead capacity including debtor possession successor assigns including trustee shall interfere with amgen right under this agreement arrowhead licensed technology including such embodiment including right obtain such arrowhead licensed technology such embodiment from another entity extent provided section bankruptcy code nbsp nbsp right power remedy amgen provided herein addition substitution other right power remedy hereafter existing equity including bankruptcy code event commencement case under bankruptcy code with respect arrowhead party agree that they intend following right extend maximum extent permitted enforceable under section bankruptcy code right access arrowhead licensed technology including embodiment thereof arrowhead third party with whom arrowhead contract perform obligation arrowhead under this agreement case third party which necessary font font style font weight normal develop font font style font weight normal ment font font style font weight normal manufacture font font style font weight normal font font style font weight normal supply font font style font weight normal commercialization sale import export licensed compound licensed product case solely provided under this agreement right contract directly with third party complete same font font style font weight normal name _dv_m name _toc font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font severability font style font weight normal name _dv_m name _toc nbsp nbsp more provision this agreement held invalid unenforceable court competent jurisdiction from which appeal taken provision shall considered severed from this agreement shall serve invalidate remaining provision hereof nbsp nbsp party shall make good faith effort replace invalid unenforceable provision with valid enforceable such that objective contemplated party when entering this agreement realized font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _dv_m name _toc font style margin left font waiver font style font weight normal name _dv_m name _toc nbsp nbsp delay enforcing party right under this agreement waiver particular default other matter shall constitute waiver such party right future enforcement right under this agreement except with respect express written signed waiver relating particular matter particular period time font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font independent contractor font style font weight normal nbsp nbsp each party shall solely independent contractor nothing this agreement shall construed give either party power authority bind commit other party nbsp nbsp nothing herein shall construed create relationship partner principal agent joint venture partner between party font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font third party beneficiary font style font weight normal nbsp nbsp this agreement neither expressly impliedly made benefit party other than party their successor permitted assigns except person expressly entitled indemnification provided article only accordance with term such article font style text align justify margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style margin left font counterpart electronic delivery font style font weight normal nbsp nbsp this agreement executed counterpart original facsimile signature each which shall deemed original which together shall constitute same instrument nbsp nbsp signature this agreement transmitted facsimile email portable document format font style margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font weight bold font style italic font size font family time roman text transform none font variant normal nbsp style text align justify margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style font size font family time roman font weight normal font style normal text transform none font variant normal other electronic mean intended preserve original graphic pictorial appearance this agreement shall have same effect physical delivery paper document bearing original signature font style margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal name _dv_m signature page follows style margin bottom margin text indent font family time roman font size nbsp style text align center margin margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal style line height margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration none font font style text decoration none font weight normal font font style font size font weight normal margin left confidential font style page break after always width style text align right margin bottom margin text indent font family time roman font size nbsp style text align justify margin bottom margin text indent font weight bold font variant small font size font family time roman font style normal text transform none name _dv_m name _aeioulastrenderedpagebreakaeiou font style font weight bold font variant small font size font family time roman font style normal text transform none witness whereof font font style font weight normal font variant normal party have executed this agreement their duly authorized officer effective date font align left table border cellspacing cellpadding style border collapse collapse width style width style width valign style margin bottom margin margin left text indent font weight bold color font family time roman bold font variant small font size font style normal text transform none amgen valign style margin bottom margin margin left text indent font weight bold font variant small font size font family time roman font style normal text transform none arrowhead pharmaceutical style margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal nbsp valign style margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal font style text decoration underline david meline font valign style margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal font style text decoration underline chris anzalone font valign style margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal name david meline valign style margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal name nbsp nbsp chris anzalone valign style margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal title nbsp nbsp style margin bottom margin margin left text indent font family time roman font size nbsp style text align justify margin bottom margin margin left text indent font family time roman font size nbsp valign style text align justify margin bottom margin margin left text indent font size font family time roman font weight normal font style normal text transform none font variant normal title nbsp nbsp valign style margin bottom margin margin left text indent font family time roman font size nbsp style margin bottom margin margin left text indent font family time roman font size nbsp style margin bottom margin margin left text indent font family time roman font size nbsp valign style text align justify margin bottom margin margin left text indent font family time roman font size nbsp table style margin bottom margin text indent font family time roman font size nbsp style text align justify margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin text indent font family time roman font size nbsp style margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal text indent nbsp style margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal text indent nbsp style text align center margin clear both margin bottom text indent font size font family time roman font weight normal font style normal text transform none font variant normal signature page first collaboration license agreement style page break after always width style margin bottom margin text indent font family time roman font size nbsp style text align justify margin bottom margin text indent font weight bold text transform uppercase font size font family time roman font style normal font variant normal name _dv_m name _aeioulastrenderedpagebreakaeiou font style font weight bold text transform uppercase font size font family time roman font style normal font variant normal list exhibit font style text align justify margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal name _dv_m name _dv_m exhibit font style margin left name _dv_m collaboration target font style text align justify margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal exhibit font style margin left font research plan outline style text align justify margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal name _dv_c exhibit font style margin left font certain arrowhead owned patent style text align justify margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal name _dv_c exhibit font style margin left font certain arrowhead licensed patent style text align justify margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal exhibit font style margin left font third party license agreement style text align justify margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal exhibit font style margin left initial press release font style text align justify margin bottom margin text indent font family time roman font size nbsp style margin line height margin bottom text indent font family time roman font size nbsp style page break after always width style margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style text decoration underline exhibit font style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal collaboration target style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal style margin line height margin bottom text indent font family time roman font size nbsp style page break after always width style margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style text decoration underline exhibit font style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal research plan outline style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal style margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal style margin line height margin bottom text indent font family time roman font size nbsp style page break after always width style margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style text decoration underline exhibit font font style text decoration underline font style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal certain arrowhead owned patent style font size vertical align style font size vertical align style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal style text align center margin bottom margin text indent font family time roman font size nbsp align left table border cellspacing cellpadding style border collapse collapse width style width valign style border bottom solid style margin bottom margin margin left text indent font size nbsp table align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font size font family calibri font weight normal font style normal text transform none font variant normal font style font size font family calibri font weight normal font style normal text transform none font variant normal style font size vertical align nbsp font valign style width style margin bottom margin font size font family calibri font weight normal font style normal text transform none font variant normal table style margin line height margin bottom text indent font family time roman font size nbsp style page break after always width style margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal font style text decoration underline exhibit font style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal certain arrowhead licensed patent style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal style text align center margin bottom margin text indent font family time roman font size nbsp style margin line height margin bottom text indent font family time roman font size nbsp style page break after always width style margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin text indent font weight bold font size font family time roman font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou font style text decoration underline exhibit font font style text decoration underline font font style text decoration underline font style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal third party license agreement align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size nbsp valign style width white space nowrap style margin bottom margin font family time roman font size font weight normal font style normal text transform none font variant normal font style font family time roman font size font weight normal font style normal text transform none font variant normal font valign style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size font style font family time roman asset purchase exclusive license agreement between arrowhead research corporation novartis institute biomedical research dated march font table style margin bottom margin margin left text indent font family time roman font size nbsp align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size nbsp valign style width white space nowrap style margin bottom margin font family time roman font size font weight normal font style normal text transform none font variant normal font style font family time roman font size font weight normal font style normal text transform none font variant normal font valign style margin bottom margin font weight normal font style normal text transform none font variant normal font family time roman font size font style font family time roman exclusive license agreement between city hope hoffmann roche hoffmann roche dated september nbsp nbsp font table style margin bottom margin margin left text indent font family time roman font size nbsp align left table border cellspacing cellpadding style border collapse collapse width valign style width white space nowrap style margin margin bottom font weight normal font style normal text transform none font variant normal font family time roman font size nbsp valign style width white space nowrap style margin margin bottom font family time roman font size font weight normal font style normal text transform none font variant normal font style font family time roman font size font weight normal font style normal text transform none font variant normal font valign style margin margin bottom font weight normal font style normal text transform none font variant normal font family time roman font size font style font family time roman exclusive license agreement between hoffmann roche hoffmann roche mdrna dated february font table style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal name _aeioulastrenderedpagebreakaeiou style margin margin bottom text indent font family time roman font size nbsp style page break after always width style margin bottom margin text indent font family time roman font size nbsp style text align center margin bottom margin font size font family time roman font weight normal font style normal text transform none font variant normal font style font weight bold text decoration underline exhibit font font style font weight bold text decoration underline font style text align center margin bottom margin text indent font size font family time roman font weight normal font style normal text transform none font variant normal initial press release style text align center margin bottom margin text indent font family time roman font size nbsp style margin line height margin bottom text indent font family time roman font size nbsp body html text document